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Background: We herein evaluate the Spanish population ? s trends in health burden by comparing results of two
Global Burden of Diseases, Injuries, and Risk Factors Studies (the GBD studies) performed 20 years apart.
Methods: Data is part of the GBD study for 1990 and 2010. We present results for mortality, years of life lost (YLLs),
years lived with disability, and disability-adjusted life years (DALYs) for the Spanish population. Uncertainty intervals
for all measures have been estimated.
Results: Non-communicable diseases accounted for 3,703,400 (95% CI 3,648,270? 3,766,720) (91.3%) of 4,057,400 total
deaths, in the Spanish population. Cardiovascular and circulatory diseases were the main cause of mortality among
non-communicable diseases (34.7% of total deaths), followed by neoplasms (27.1% of total deaths). Neoplasms,
cardiovascular and circulatory diseases, and chronic respiratory diseases were the top three leading causes for YLLs. The
most important causes of DALYs in 2010 were neoplasms, cardiovascular and circulatory diseases, musculoskeletal
disorders, and mental and behavioral disorders.
Conclusions: Mortality and disability in Spain have become even more linked to non-communicable diseases over the
last years, following the worldwide trends. Cardiovascular and circulatory diseases, neoplasms, mental and behavioral
disorders, and neurological disorders are the leading causes of mortality and disability. Specific focus is needed from
health care providers and policy makers to develop health promotion and health education programs directed towards
non-communicable disorders.
Keywords: Disability-adjusted life years, Global Burden of Diseases, Injuries, and Risk Factors Studies, Spain, Mortality,
Years lived with disability, Years of life lostBackground
The impact of diseases and injures on population health is
usually assessed with measures of mortality and non-fatal
health outcomes [1]. These estimates are used to signal
the most relevant public health problems, allow compari-
son between different populations and different health
conditions, and assess changes over time. The only com-
prehensive effort to date to estimate summary measures
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unless otherwise stated.region, is the ongoing Global Burden of Diseases, Injuries,
and Risk Factors (GBD) initiative [2,3].
The first GBD study analyzed data from 1990 [4] and
was published in 1993. Since then, a number of updates
have been published [5]. The Global Burden of Diseases,
Injuries, and Risk Factors Study 2010 (GBD 2010) has
updated and expanded previous efforts to include 1,160
diseases and injury sequelae from the previous analysis,
which included 483 diseases. The most important limita-
tion of previous GBD studies is that results were not es-
timated with uncertainty [6]. Specifically, uncertainty
can come from many sources, including heterogeneity in
the empirical data that are available and uncertainty in
the indirect estimation models used to make predictions
for populations with little or no data. However, this. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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GBD 2010 study.
The GBD initiative uses disability-adjusted life years
(DALYs) and mortality as the summary measurements of
the impact of health conditions on population health. The
DALY combines the years of life lost (YLLs) due to prema-
ture mortality and the years lived with disability (YLDs).
The use of DALYs as measure of impact, the inclusion of
a large number of communicable and non-communicable
conditions, the analysis of the impact of health conditions
stratified by gender and age, and the effort to use compar-
able methodologies across countries and regions make the
GBD project an excellent tool to understand the determi-
nants of health and their variability across time and re-
gions. According to previous reported global results, in
1990, 47% of DALYs were attributed to communicable,
maternal, neonatal, and nutritional disorders, 43% to non-
communicable diseases, and 10% to injuries, while in 2010,
this had reversed to 35%, 54%, and 11%, respectively [5]. Be-
sides clear differences among countries with different socio-
economic conditions, heterogeneity is also present when
analyzing and comparing countries with more similar socio-
economic conditions. For example, in the United Kingdom
(UK), mortality and disability as well as overall health has
improved in absolute terms between 1990 and 2010. How-
ever, according to Murray et al. [7], the UK performed worse
than other EU countries in age-standardized mortality,
YLLs, and life expectancy rates. The UK age-standardized
DALY rates for chronic obstructive pulmonary disease,
disorders of drug use, lower respiratory infections,
breast cancers, and preterm birth complications were
significantly higher compared to the mean of the EU-15
area countries [7].
Spain is a southern European country with distinct
sociodemographic and health characteristics; while in
former years large proportions of the population adhered
to a Mediterranean diet, dietary habits are changing rap-
idly with alarming rates of obesity and smoking and alco-
hol drinking are still highly prevalent in the country
despite public health efforts to reduce consumption.
Nevertheless, the, until recently, universal coverage of the
National Health System also facilitates good health care
levels and the implementation of some preventive actions.
Until now, to the best of our knowledge, only two studies
have tried to assess the burden of disease in Spain.
Genova-Maleras et al. [8] estimated the impact of different
diseases using DALYs. According to the researchers, the
DALYs due to all diseases and injuries were estimated at
5.1 million in Spain. Almost 90% of these were attributed
to chronic diseases. Specifically, the leading causes of
DALYs were neurological and mental disorders, followed
by malignant neoplasms and cardiovascular diseases [8].
However, the aforementioned results were partially lim-
ited, since the mortality data came from Spanish registers,while the incidence and severity rates were obtained from
estimations of the WHO for a variety of European coun-
tries (i.e., WHO European Region Eur-A). A more recent
project, but only including data from Valencia, revealed
similar results [9], reporting that the number of DALYs
gradually increased with age and almost 27% of all DALYs
occurred among people over the age of 70 [9].
Given the scarcity of analysis of the data from Spain
and the relevance of learning from the experience and
comparison with similar and not so similar countries,
the aim of the present work was to evaluate the change
in burden of disease in Spain, comparing the available
data of the GBD over time, between 1990 and 2010.
Methods
Overview
The GBD 2010 study estimates the impact of 291 diseases
and injuries and 67 risk factors for 187 countries distri-
buted into 21 world regions between 1990 and 2010. For
each cause, 1 to 24 sequelae were defined. Sequelae are
the clinical outcomes that can be related to specific dis-
eases and injuries such as neuropathy due to diabetes.
In total, the study includes 1,160 sequelae. More de-
tailed information about data and analysis for the GBD
2010 have been previously reported [2,5,6,10,11]. For
the present analysis, only information regarding Spain
will be reported.
Measurements
We report data on mortality, YLLs due to premature mor-
tality, YLDs, and DALYs. Age-specific mortality rates for
Spain were estimated for each sex. As in other developed
countries, information about deaths was predominantly
driven by data from official vital registration systems [12].
The denominators were based on Spanish census returns
and intercensal estimates. Similarly to the other 187 coun-
tries of the GBD study, the estimated number of deaths
and YLLs was based on 235 defined underlying causes of
mortality from the list of 291 diseases and injuries, for 20
age groups and both sexes [2,13]. The YLLs were com-
puted by multiplying the number of deaths in each age
group by a reference life expectancy [2]. The YLDs were
computed by multiplying the prevalence of a sequelae by
its disability weight (DW), used to quantify population? s
health losses. This procedure varies slightly compared to
previous GBD studies, in which incidence and average
duration of the case until remission was used instead of
prevalence [14]. A total of 1,160 possible sequelae of dis-
eases and injuries were analyzed. Murray et al. [5] have de-
scribed the systematic analysis of available data conducted
for each sequelae with regard to the prevalence, incidence,
remission, and excess mortality. For each age-sex-year
group, estimates were made for most sequelae using
Bayesian meta-regression methods. DWs were obtained
Table 1 Spanish population (millions) in 1990 and 2010
1990 2010 Δ%
Both sexes, all ages 38,914,907 44,558,264 15
0? 19 years old 11,078,521 8,781,618 −21
20? 39 years old 11,618,044 13,004,297 12
40? 59 years old 8,820,927 12,589,546 43
60? 79 years old 6,240,651 7,878,252 26
80+ years old 1,156,764 2,304,554 99
Males, all ages 19,057,590 21,964,405 15
Females, all ages 19,857,317 22,593,859 14
Haro et al. BMC Medicine 2014, 12:236 Page 3 of 25
http://www.biomedcentral.com/1741-7015/12/236for 220 health states covering the 1,160 sequelae [6]. For
each sequelae, DWs were derived based on the scoring of
short lay descriptions of the relevant health domains in
large population-based studies in several countries (i.e.,
Peru, USA) and through an open internet survey [15]. Fi-
nally, for the estimation of the DALYs, the arithmetic sum
of YLLs and YLDs was used.
The YLDs age-standardized rates for each cause, in 1990
and 2010, were calculated. For this procedure the WHO
age-standard was used as has been described in former
GBD analyses [16]. Spain? s YLDs age-standardized rank-
ings were compared with other European countries. The
aforementioned comparison of YLDs age-standardized
rates provides an opportunity to compare the YLDs across
the European countries in specific periods, controlling for
number variations and crude rates due to differences in
population age.
In order to differentiate the change in DALYs due to
demographic variations from those to health changes or
other reasons, two counterfactual increases in total
DALYs were calculated based on the 1990 population
sex and age distribution and compared with the ob-
served increase from 1990 to 2010: i) the expected in-
crease in total DALYs if total population increase had
been as observed but without change in the age/sex
structure or in strata-specific DALY rates; ii) the ex-
pected increase in total DALYs if the population and its
age/sex structure had changed as observed but without
change in strata-specific DALY rates (application of
1990 stratum-specific DALY rates to the 2010 popu-
lation strata sizes). The first estimate, (i), provides the
increase attributable to population increase without
population aging; (ii) minus (i) gives the increase attrib-
utable to population aging and the observed increase
from 1990 to 2010 minus (ii) gives the increase attribut-
able to changes in stratum-specific DALY rates.
Uncertainty levels
Uncertainty levels for mortality rate were estimated
using standard simulation methods [2]. Uncertainty for
mortality and YLLs reflected uncertainty in the levels of
all-cause mortality and uncertainty in the estimation of
each mortality cause, in each age group, sex, and year.
Uncertainty in the disability weight for each sequelae
was propagated into the estimates of YLDs for each dis-
ease and injury. For a more accurate estimation of
YLDs, the effect of comorbidity was taken into account,
as explained in Vos et al. [10]. Specifically, the proced-
ure of microsimulation for each country (explicitly here
for Spain), age, sex, and year were used in a large num-
ber of simulated individuals. This standard simulation
method was repeated 1,000 times to be able to capture
uncertainty in the prevalence of all sequelae and disabil-
ity weights [10].Results
From 1990 to 2010, the overall Spanish population in-
creased by almost 15% (from 38,914,907 to 44,558,264
people) (Table 1). A similar increase was observed in males
and females, close to 15% and 14%, respectively. The popu-
lation of older adults in Spain presented the highest in-
crease among all age groups. For example, in octogenarians
(aged 80+ years), the increase was almost double. The high-
est decrease of population was observed in the younger ages
(0? 20 years old), where the population dropped by 21%.
Table 2 illustrates the main causes of mortality and YLLs
by gender and age group for the Spanish population. As
expected, non-communicable diseases were the major
cause of mortality, accounting for 3,703,400 (95% CI
3,648,270 ? 3,766,720) (91.3%) of 4,057,400 total deaths.
Cardiovascular and circulatory diseases were the main
cause of mortality among the non-communicable dis-
eases (34.7% of total deaths), followed by neoplasms
(27.1% of total deaths). The third category, injuries,
accounted for 4.1% of Spanish deaths [170,040, 95% CI
(148,350 ? 187,710)].
Age-specific analysis revealed that non-communicable
diseases remained the major cause of mortality except
for children below 1 year of age. Cardiovascular- and
circulatory-related mortality raised with ageing, from
6% of deaths in individuals younger than 20 years old to
almost 41% in those 80 years old and over. Neoplasm-
related mortality was almost 22% of deaths in individ-
uals aged up to 40 years, nearly doubled in the group
aged 40 ? 79 years and finally dropped to 17% in the
group of octogenarians. On the contrary, the main cause
of mortality in newborns was communicable diseases,
which accounted for 61.5% of all deaths within the group.
In regard to gender differences, the main cause of male
mortality was neoplasms (33%), followed by cardiovascular
diseases (30.3%), chronic respiratory diseases (9.5%), neuro-
logical diseases (5.3%), and injuries (5.2%). On the other
hand, the main cause of female mortality were cardiovas-
cular diseases (39.4%) followed by neoplasms (21.4%),
neurological disorders (9.4%), and the group formed by
Table 2 Main causes of mortality and years of life lost (YLLs) by age groups and by gender, for the Spanish population in 2010
Deaths (hundreds) YLLs (hundreds)
Both sexes, all ages <1
year
1 ? 19
years
20? 39
years
40 ? 59
years
60 ? 79
years
80+
years
Males, all ages Females, all ages Both sexes, all ages Males, all ages Females, all ages
All causes 4,057.4 16.9 14.9 74.9 345.6 1,283.0 2,322.2 2,049.9 2,007.5 54,562.8 32,736.3 21,826.5
Communicable, maternal,
neonatal, and nutritional
disorders
183.96
(157.53 ? 214.88)
10.4 1.3 5.8 14.3 35.6 116.6 89.84
(74.84? 110.39)
94.12
(75.54 ? 117)
3,124.9
(2,873.32 ? 3,397.56)
1,818.74
(1,629.9 ? 2,038.1)
1,306.17
(1,154.6 ? 1,471.72)
HIV/AIDS and tuberculosis 16.76
(14.7? 19.39)
0.0 0.0 3.6 7.5 3.0 2.8 12.12
(10.21? 14.78)
4.63
(3.85? 5.63)
555.31
(480.43 ? 649.07)
420.04
(349.4 ? 512.85)
135.27
(115.48 ? 159.21)
Diarrhea, lower respiratory
infections, meningitis, and
other common infectious
diseases
138.1
(113.55 ? 169.75)
0.4 0.7 1.5 5.2 27.8 102.4 64.36
(49.5? 85.36)
73.75
(55.79 ? 96.84)
1,432.97
(1,244.82 ? 1,680.97)
783.48
(640.77 ? 986.07)
649.49
(534.56 ? 788.48)
Neglected tropical diseases
and malaria
1.66
(0.84? 3.19)
0.0 0.0 0.0 0.0 0.3 0.5 0.62
(0.31? 1.14)
1.04
(0.4 ? 2.45)
49.34
(27.47 ? 89.06)
20.64
(11.35 ? 36.68)
28.7
(11.85 ? 61.85)
Maternal disorders 0.32
(0.22? 0.42)
0.0 0.0 0.0 0.0 0.0 0.0 ? * 0.32
(0.22? 0.42)
16.2
(10.86 ? 21.52)
? * 16.2
(10.86 ? 21.52)
Neonatal disorders 9.8
(8.54? 11.03)
9.8 0.0 0.0 0.0 0.0 0.0 5.5
(4.63? 6.4)
4.3
(3.4 ? 5.11)
842.8
(734.44 ? 948.51)
473.06
(398.16 ? 550.48)
369.74
(292.36 ? 439.4)
Nutritional deficiencies 9.52
(5.24? 13.19)
0.0 0.0 0.0 0.0 1.3 7.8 3.24
(1.82? 4.57)
6.29
(2.72? 9.74)
82.92
(48.12 ? 106.53)
35.8
(20.2 ? 45.91)
47.12
(22.07 ? 68.11)
Other communicable, maternal,
neonatal, and nutritional
disorders
7.79
(5.07? 9.57)
0.0 0.0 0.1 1.1 3.1 3.1 4
(2.37? 5.02)
3.8
(2.32? 5.06)
145.36
(100.68 ? 168.33)
85.71
(56.07 ? 102.53)
59.64
(39.63 ? 73.75)
Non-communicable diseases 3,703.42
(3,648.27 ? 3,766.72)
6.1 7.5 39.6 297.0 1.205.7 2.147.2 1,853.9
(1,818.92 ? 1,891.49)
1,849.53
(1,807.93 ? 1,895.78)
46,970.31
(46,249.68 ? 48,068.86)
27,624.78
(27,059.44 ? 28,507.45)
19,345.53
(18,957.63 ? 19,922.49)
Neoplasms 1,101.24
(1,014.78 ? 1,168.33)
0.0 3.2 16.5 166.4 513.7 401.3 671.72
(603.52 ? 728.99)
429.52
(386.58 ? 469.72)
18,488.09
(17,216.3 ? 19,429.35)
11,636.36
(10,542.8 ? 12,486.19)
6851.73
(6324.27 ? 7307.47)
Esophageal cancer 19.45
(14.41 ? 26.46)
0.0 0.0 0.0 4.9 9.9 4.6 16.47
(11.79? 23.21)
2.97
(1.89? 4.47)
388.59
(286.84 ? 536.01)
349.47
(253.61 ? 493.6)
39.11
(23.43 ? 53.73)
Stomach cancer 64.9
(49.72 ? 93.74)
0.0 0.0 0.7 7.9 29.2 27.1 36.68
(24.69? 52.52)
28.22
(18.13 ? 51.95)
986.61
(741.61 ? 1,378.18)
613.71
(403.16 ? 859.83)
372.9
(229.02 ? 636.47)
Liver cancer 52.14
(42.39 ? 65.26)
0.0 0.0 0.3 6.8 26.6 18.2 32.93
(25.09? 42.88)
19.2
(14.55 ? 28.42)
837.17
(701.49 ? 1,036.73)
591.1
(470.26 ? 768.21)
246.07
(197.75 ? 342.93)
Larynx cancer 17.38
(9.03? 31.26)
0.0 0.0 0.0 4.8 8.9 3.6 16.56
(8.38? 30.24)
0.83
(0.38? 1.31)
361.52
(190.52 ? 673.47)
348.38
(180.74 ? 659.95)
13.14
(5.59 ? 22.2)
Trachea, bronchus, and lung
cancers
191.92
(123.09 ? 218.32)
0.0 0.0 1.3 39.2 105.4 46.0 163.47
(99.12? 188.56)
28.45
(12.43 ? 35.7)
3,641.21
(2,366.65 ? 4,115.82)
3,088.96
(1,923.35 ? 3,509.43)
552.25
(221.23 ? 698.17)
Breast cancer 65.87
(58.98 ? 73.57)
0.0 0.0 2.0 16.6 24.7 22.5 ? * 65.87
(58.98 ? 73.57)
1281.35
(1177.3 ? 1410.43)
? * 1,281.35
(1,177.3 ? 1,410.43)
Cervical cancer 9.09
(5.98? 13.94)
0.0 0.0 0.4 2.9 3.3 2.4 ? * 9.09
(5.98? 13.94)
207.1
(130.86 ? 301.52)
? * 207.1
(130.86 ? 301.52)
Uterine cancer 12.5
(5.29? 17.15)
0.0 0.0 0.0 1.2 6.3 5.0 ? * 12.5
(5.29? 17.15)
181.01
(81.49 ? 256.02)
? * 181.01
(81.49 ? 256.02)
H
aro
et
al.BM
C
M
edicine
2014,12:236
Page
4
of
25
http://w
w
w
.biom
edcentral.com
/1741-7015/12/236
Table 2 Main causes of mortality and years of life lost (YLLs) by age groups and by gender, for the Spanish population in 2010 (Continued)
Prostate cancer 76.48
(43.85 ? 133.33)
0.0 0.0 0.0 1.3 29.5 45.7 76.48
(43.85? 133.33)
? * 818.99
(459.29 ? 1,372.44)
818.99
(459.29 ? 1,372.44)
? *
Colon and rectum cancers 160.31
(126.24 ? 180.29)
0.0 0.0 1.1 16.9 71.9 70.3 90.85
(66.16? 104.65)
69.46
(50.39 ? 82.73)
2,323.71
(1,897.63 ? 2,571.55)
1,399.22
(1,060.67 ? 1,580.73)
924.49
(704.14 ? 1,098.13)
Mouth cancer 13.87
(11.62 ? 16.79)
0.0 0.0 0.1 3.7 6.2 3.6 10.33
(8.48? 13.11)
3.54
(2.14? 4.85)
282.8
(236.88 ? 352.29)
230.16
(187.58 ? 298.5)
52.65
(31.34 ? 70.41)
Nasopharynx cancer 2.61
(1.64? 3.53)
0.0 0.0 0.0 0.8 1.2 0.5 1.96
(1.14? 2.91)
0.65
(0.31? 1.05)
62.2
(39.43 ? 87.48)
49.32
(29.12 ? 74.66)
12.88
(6.14 ? 19.83)
Cancer of other part of
pharynx and oropharynx
8.63
(4.93? 11.43)
0.0 0.0 0.0 3.2 4.1 1.2 7.5
(4.12? 10.7)
1.13
(0.48? 1.83)
206.07
(118.56 ? 292.36)
185.2
(104.09 ? 277.98)
20.87
(8.52 ? 33.12)
Gallbladder and biliary tract
cancer
19.93
(13.61 ? 30.72)
0.0 0.0 0.0 1.4 9.3 9.0 7.04
(4.22? 11.03)
12.89
(7.14? 22.96)
269.16
(187.54 ? 408.35)
107.66
(65.4 ? 163.82)
161.5
(88.78 ? 288.73)
Pancreatic cancer 53.44
(38.17 ? 70.44)
0.0 0.0 0.3 7.6 27.4 18.0 27.66
(17.79? 36.7)
25.78
(15.56 ? 39.61)
875.5
(637.54 ? 1,113.72)
517.94
(335.01 ? 680.03)
357.56
(215.21 ? 544.31)
Malignant melanoma of skin 9.36
(5.58? 13.09)
0.0 0.0 0.5 2.2 3.8 2.7 5.14
(2.28? 8.31)
4.22
(2.23? 6.97)
198.46
(125.2 ? 285.93)
114.49
(55.15 ? 197.21)
83.97
(46.36 ? 131.3)
Non-melanoma skin cancer 6.79
(4.12? 11.36)
0.0 0.0 0.0 0.3 1.6 4.7 3.57
(1.72? 6.74)
3.23
(1.42? 7.1)
72.93
(44.47 ? 125.29)
46.17
(22.35 ? 90.37)
26.75
(11.84 ? 56.5)
Ovarian cancer 21.15
(13.35 ? 27.17)
0.0 0.0 0.4 5.0 10.1 5.6 ? * 21.15
(13.35 ? 27.17)
415.83
(277.13 ? 553.19)
? * 415.83
(277.13 ? 553.19)
Testicular cancer 0.66
(0.32? 1.1)
0.0 0.0 0.0 0.0 0.0 0.1 0.66
(0.32? 1.1)
? * 21.3
(11.38 ? 31.3)
21.3
(11.38 ? 31.3)
? *
Kidney and other urinary
organ cancers
34.18
(24.57 ? 56.41)
0.0 0.0 0.2 5.2 16.8 11.8 21.44
(14.98? 41.31)
12.74
(7.01? 23.93)
574.91
(420.5 ? 941.19)
385.7
(278.74 ? 736.03)
189.21
(108.55 ? 335.81)
Bladder cancer 49.77
(34.6? 60.6)
0.0 0.0 0.0 3.6 22.1 24.1 39.86
(24.7? 50.26)
9.91
(7.13? 13)
654.29
(461.6 ? 771.51)
549.7
(357.15 ? 673.67)
104.6
(77.76 ? 128.75)
Brain and nervous system
cancers
35.98
(19.75 ? 47.79)
0.0 0.9 2.0 8.4 17.2 7.5 19.01
(7.63? 26.36)
16.96
(6.63? 25.86)
830.9
(476.65 ? 1,032.05)
470.77
(201.2 ? 635.62)
360.13
(155.29 ? 483.64)
Thyroid cancer 3.59
(2.59? 4.71)
0.0 0.0 0.0 0.3 1.7 1.4 1.2
(0.67? 1.73)
2.39
(1.48? 3.39)
57.39
(42.19 ? 73.87)
23.49
(12.68 ? 33.42)
33.91
(21.28 ? 47.35)
Hodgkin's disease 2.65
(1.69? 3.95)
0.0 0.0 0.3 0.4 1.1 0.6 1.43
(0.72? 2.35)
1.22
(0.6 ? 2.06)
70.16
(46.16 ? 106.97)
41.58
(21.53 ? 69.86)
28.59
(14.86 ? 49.59)
Non-Hodgkin lymphoma 27.11
(17.91 ? 33.76)
0.0 0.0 1.0 4.0 12.6 9.3 14.12
(8.57? 17.92)
12.98
(6.48? 17.22)
487.31
(353.12 ? 563.21)
283.95
(184.07 ? 336.15)
203.35
(113.58 ? 246.19)
Multiple myeloma 17.81
(11.24 ? 25.25)
0.0 0.0 0.0 1.6 9.7 6.4 8.93
(4.6 ? 15.05)
8.88
(4.49? 14.08)
267.24
(175.37 ? 381.15)
142.53
(75.4 ? 242.08)
124.71
(64.53 ? 196.93)
Leukemia 39.1
(27.64 ? 48.47)
0.0 0.9 1.5 3.8 16.3 16.6 22.79
(13.64? 28.19)
16.31
(8.25? 23.37)
672.27
(529 ? 803.1)
406.11
(272.07 ? 491.1)
266.16
(149.02 ? 354.36)
Other neoplasms 84.59
(64.71 ? 111.97)
0.0 0.8 2.2 11.6 37.0 32.9 45.63
(29.95? 69.82)
38.96
(25.69 ? 58.6)
1,442.11
(1,134.05 ? 1,965.74)
850.47
(589.15 ? 1,306.45)
591.64
(403.56 ? 900.02)
Cardiovascular and circulatory
diseases
1,411.99
(1,323.93 ? 1,541.5)
0.2 0.9 9.8 70.4 374.6 956.1 621.16
(583.59 ? 657.16)
790.83
(714.8 ? 921.4)
1,4937.05
(1,4229.38 ? 1,6134.05)
8,344.88
(7,929.4 ? 8,713.27)
6,592.17
(6,047.73 ? 7,708.66)
Rheumatic heart disease 36.79
(29.03 ? 45.78)
0.0 0.0 0.1 1.3 9.4 25.7 8.77
(5.83 ? 11.22)
28.02
(21.11 ? 36.12)
368.29
(308.32 ? 428.92)
117.17
(78.95 ? 138.38)
251.12
(204.52 ? 302.84)
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Table 2 Main causes of mortality and years of life lost (YLLs) by age groups and by gender, for the Spanish population in 2010 (Continued)
Ischemic heart disease 626.56
(577.22 ? 692.18)
0.0 0.1 4.9 40.2 178.0 403.3 308.45
(282.37 ? 349.41)
318.11
(282.55 ? 370.95)
7,081
(6,637.38 ? 7,802.67)
4,428.89
(4,114.2 ? 4,977.74)
2,652.11
(2,409.27 ? 3,107.44)
Cerebrovascular disease 429.4
(368.79 ? 561.38)
0.0 0.1 1.9 14.0 103.2 310.0 171.63
(142.42 ? 222.99)
257.77
(213.81 ? 366.07)
4,112.36
(3,640.69 ? 5,216.74)
2,003.92
(1,732.92 ? 2,516.07)
2,108.44
(1,807.93 ? 2,964.23)
Hypertensive heart disease 63.64
(47.68 ? 83.36)
0.0 0.0 0.1 1.6 12.9 48.8 21.25
(15.45? 26.68)
42.38
(27.82 ? 62.1)
566.48
(445.62 ? 709.6)
242.98
(183.82 ? 285.61)
323.5
(216.24 ? 460.26)
Cardiomyopathy and
myocarditis
50.88
(43.67 ? 60.5)
0.0 0.0 1.1 4.8 16.3 28.4 28.21
(22.58? 36.59)
22.67
(18.15 ? 27.22)
697.3
(611.01 ? 826.99)
470.92
(389.76 ? 589.69)
226.37
(192.37 ? 257.76)
Atrial fibrillation and flutter 49.57
(29.32 ? 78.88)
0.0 0.0 0.0 0.3 8.8 40.5 16.36
(8.17? 30.95)
33.21
(16.15 ? 60.01)
388.35
(250.38 ? 588.8)
156.64
(84.08 ? 278.6)
231.71
(129.37 ? 389.33)
Aortic aneurysm 22.1
(16.23 ? 29.05)
0.0 0.0 0.1 1.8 9.8 10.2 16.99
(11.53? 23.56)
5.11
(3.65? 8.83)
308.17
(224.6 ? 403.06)
251.95
(169.97 ? 345.83)
56.22
(45.13 ? 84.66)
Peripheral vascular disease 13.51
(7.89? 21.83)
0.0 0.0 0.0 0.1 2.8 10.5 4.27
(1.77? 8.98)
9.24
(4.84? 16.38)
113.92
(69.2? 182.18)
49.4
(20.22 ? 100.5)
64.52
(37.27 ? 112.09)
Endocarditis 4.85
(3.53? 5.85)
0.0 0.0 0.0 0.3 1.6 2.6 2.32
(1.68? 2.94)
2.53
(1.48? 3.34)
68.91
(52.71 ? 80.35)
39.65
(30.25 ? 47.19)
29.26
(17.32 ? 36.84)
Other cardiovascular and
circulatory diseases
114.69
(103.64 ? 128.09)
0.0 0.0 1.1 5.2 31.8 76.3 42.9
(38.16? 47.72)
71.79
(61.6? 84.61)
1,232.26
(1,151.54 ? 1,317.41)
583.36
(538.22 ? 631.15)
648.9
(582.6 ? 724.27)
Chronic respiratory diseases 314.29
(290.3 ? 340.56)
0.0 0.0 0.9 7.7 85.1 220.4 184.71
(168.12 ? 201.48)
129.58
(112.04 ? 149.2)
3,042.65
(2,862.02 ? 3,232.05)
1,988.91
(1,853.32 ? 2,124.11)
1,053.75
(943.48 ? 1,173.44)
Chronic obstructive
pulmonary disease
186.69
(161.55 ? 210.12)
0.0 0.0 0.1 4.1 54.2 128.0 127.89
(102.9? 151.05)
58.8
(51.86 ? 66.3)
1,816.89
(1,581.96 ? 2,035.79)
1,350.53
(1,113.46 ? 1,566.59)
466.36
(424.85 ? 510.99)
Pneumoconiosis 14.55
(9.49? 21.14)
0.0 0.0 0.0 0.3 4.1 10.1 8.41
(4.68? 13.84)
6.14
(3.08? 10.78)
142.94
(95.3? 207.26)
95.76
(55.91 ? 154.49)
47.18
(24.97 ? 78.07)
Asthma 10.82
(8.31? 14.66)
0.0 0.0 0.0 0.5 3.0 7.0 2.48
(1.66? 5.71)
8.34
(5.6 ? 10.39)
126.37
(103.62 ? 173.86)
39.76
(28.92 ? 83.48)
86.61
(61.65 ? 101.64)
Interstitial lung disease and
pulmonary sarcoidosis
19.91
(12.32 ? 29.59)
0.0 0.0 0.0 1.0 8.9 10.0 10.94
(5.81? 19.32)
8.98
(4.04? 15.82)
246.47
(167.1 ? 353.69)
145.14
(85.09 ? 237.34)
101.33
(52.57 ? 165.72)
Other chronic respiratory
diseases
82.32
(60.89 ? 108.12)
0.0 0.0 0.2 1.6 14.9 65.3 34.99
(24.62? 53.3)
47.32
(30.81 ? 69.1)
709.98
(577.64 ? 969.25)
357.72
(274.56 ? 541.95)
352.26
(248.4 ? 502.74)
Cirrhosis of the liver 88.53
(77.98 ? 111.17)
0.0 0.0 2.1 21.5 37.6 27.3 54.89
(46.88? 74.57)
33.64
(27.92 ? 44.82)
1,735.13
(1,547.01 ? 2,184.28)
1,222.34
(1,061.28 ? 1,660.84)
512.79
(438.15 ? 732.49)
Cirrhosis of the liver
secondary to hepatitis B
3.68
(3.06? 4.61)
0.0 0.0 0.0 0.8 1.6 1.2 1.93
(1.5 ? 2.69)
1.74
(1.33? 2.27)
66.56
(55.74 ? 85.12)
40.9
(31.63 ? 56.41)
25.66
(19.88 ? 34.09)
Cirrhosis of the liver
secondary to hepatitis C
38.7
(32.55 ? 49.19)
0.0 0.0 0.4 7.2 17.5 13.6 18.92
(14.59? 26.86)
19.78
(15.03 ? 26.26)
672.7
(569.42 ? 857.44)
389.74
(303.2 ? 550.58)
282.96
(221.68 ? 386.87)
Cirrhosis of the liver
secondary to alcohol use
38.53
(32.41 ? 50.61)
0.0 0.0 1.1 10.9 15.9 10.6 29.81
(23.69? 41.15)
8.72
(6.93? 11.34)
812.93
(675.37 ? 1,067.51)
676.87
(540.63 ? 931.27)
136.05
(110.95 ? 182.42)
Other cirrhosis of the liver 7.62
(6.34? 9.58)
0.0 0.0 0.4 2.7 2.5 1.9 4.24
(3.29? 6)
3.39
(2.63? 4.49)
182.95
(152.89 ? 235.21)
114.82
(89.6 ? 162.57)
68.12
(53.84 ? 96.43)
Digestive diseases
(except cirrhosis)
129.05
(111.24 ? 145.99)
0.0 0.0 0.9 6.1 35.4 86.5 54.43
(41.68? 65.06)
74.62
(62.01 ? 87.51)
1,367.61
(1,200.26 ? 1,524.33)
712.46
(566.44 ? 835.42)
655.16
(575.25 ? 735.08)
Peptic ulcer disease 7.94
(6.12? 12.78)
0.0 0.0 0.0 0.5 2.3 5.0 3.91
(2.75? 6.09)
4.03
(2.78? 7.21)
94.36
(78.41 ? 133.23)
56.52
(42.89 ? 76.76)
37.84
(29.6 ? 60.57)
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Table 2 Main causes of mortality and years of life lost (YLLs) by age groups and by gender, for the Spanish population in 2010 (Continued)
Gastritis and duodenitis 0.7
(0.38? 1.34)
0.0 0.0 0.0 0.0 0.0 0.5 0.33
(0.15? 0.79)
0.37
(0.17? 0.83)
7.71
(4.66? 14)
4.37
(2.43 ? 9.64)
3.34
(1.85 ? 6.94)
Appendicitis 2.27
(1.25? 3.37)
0.0 0.0 0.0 0.0 0.8 1.2 0.99
(0.39? 1.73)
1.28
(0.51? 2.11)
29.43
(17.11 ? 40.96)
15.49
(6.22 ? 24.66)
13.94
(5.89 ? 20.06)
Paralytic ileus and intestinal
obstruction without hernia
18.65
(11.22 ? 27.18)
0.0 0.0 0.0 0.3 4.2 13.9 6.75
(3.24? 10.65)
11.89
(6.27? 19.31)
168.81
(105.79 ? 226.43)
73.98
(37.43 ? 107.19)
94.82
(52.72 ? 141.84)
Inguinal or femoral hernia 1.98
(1.78? 2.05)
0.0 0.0 0.0 0.0 0.4 1.4 0.87
(0.67? 0.91)
1.11
(1.07? 1.16)
19.83
(17.64 ? 20.41)
10.61
(8.46 ? 10.99)
9.22
(9? 9.53)
Non-infective inflammatory
bowel disease
3.44
(2.08? 4.92)
0.0 0.0 0.0 0.0 1.0 2.1 1.38
(0.77? 2.01)
2.05
(1.08? 3.31)
42.73
(27.98 ? 55.05)
21.53
(12.89 ? 28.54)
21.2
(12.37 ? 30.96)
Vascular disorders of
intestine
31.9
(17.39 ? 57.23)
0.0 0.0 0.0 0.9 8.9 21.9 14.29
(3.42? 38.48)
17.61
(7.83? 28.97)
311.86
(164.05 ? 601.7)
170.18
(41.36 ? 457.84)
141.68
(65.87 ? 231.55)
Gall bladder and bile duct
disease
17.51
(12.19 ? 24.68)
0.0 0.0 0.0 0.3 3.9 13.0 6.69
(3.94? 10.06)
10.82
(6.51? 17.59)
162.17
(122.46 ? 210.64)
74.29
(46.15 ? 103.25)
87.88
(57.82 ? 129.7)
Pancreatitis 13.45
(9.97? 17.26)
0.0 0.0 0.2 1.5 4.7 7.0 6.36
(4.13? 9.22)
7.08
(4.72? 10.08)
190.96
(146.04 ? 250.94)
113.47
(77.21 ? 169.87)
77.5
(54.84 ? 111.18)
Other digestive diseases 31.22
(21.1 ? 39.68)
0.0 0.0 0.1 1.6 8.9 20.4 12.85
(8.58? 16.52)
18.36
(9.95? 26.55)
339.75
(246.38 ? 418.1)
172.02
(118.95 ? 215.82)
167.73
(90.77 ? 234.96)
Neurological disorders 298.8
(200.34 ? 394.65)
0.3 0.7 1.7 6.5 64.8 224.8 109.69
(77.39? 153.19)
189.11
(95.13 ? 279.64)
2,744.5
(2,092.35 ? 3,423.72)
1,220.72
(953.14 ? 1,606.4)
1,523.78
(921.34 ? 2,077)
Alzheimer's disease and
other dementias
243.35
(144.54 ? 342.54)
0.0 0.0 0.0 1.0 44.2 198.0 81.11
(52.94? 126.3)
162.24
(67.03 ? 254.46)
1,877.24
(1,253.43 ? 2,491)
729.99
(507.22 ? 1,079.75)
1,147.26
(548.76 ? 1,699.76)
Parkinson's disease 29.53
(18.66 ? 40.27)
0.0 0.0 0.0 0.1 9.3 19.8 14.86
(7.69? 21.9)
14.67
(7.22? 22.47)
274.27
(188.02 ? 366.69)
151.03
(87.14 ? 227.06)
123.24
(69.48 ? 176.67)
Epilepsy 4.82
(3.25? 6.35)
0.0 0.0 0.4 0.8 1.2 2.0 2.47
(1.6 ? 3.31)
2.36
(1.25? 3.71)
108.12
(77.25 ? 127.15)
64.85
(42.33 ? 82.13)
43.27
(27.22 ? 55.03)
Multiple sclerosis 1.95
(1.42? 2.48)
0.0 0.0 0.0 0.8 0.7 0.2 0.83
(0.54? 1.11)
1.12
(0.7 ? 1.57)
54.54
(39.84 ? 70)
23.21
(15.26 ? 31.31)
31.33
(19.49 ? 44.75)
Other neurological disorders 19.16
(12.14 ? 26.18)
0.3 0.3 0.9 3.5 9.2 4.7 10.43
(5.95? 15.79)
8.73
(3.82? 14.32)
430.33
(278.35 ? 593.29)
251.65
(149.6 ? 392.18)
178.69
(80.22 ? 282.85)
Mental and behavioral
disorders
13.49
(9.72? 21.5)
0.0 0.1 3.9 4.2 3.2 2.2 10.37
(7.15? 18.63)
3.13
(1.83? 4.34)
453.07
(323.04 ? 797.96)
375.8
(253.67 ? 729)
77.26
(48.94 ? 109.57)
Schizophrenia 1.17
(0.61? 1.69)
0.0 0.0 0.0 0.0 0.4 0.4 0.61
(0.27? 0.9)
0.56
(0.22? 0.99)
22.53
(12.28 ? 29.9)
13.51
(6.02 ? 19.24)
9.02
(3.73 ? 13.98)
Alcohol use disorders 4.36
(2.61? 8.97)
0.0 0.0 0.2 2.0 1.7 0.4 3.82
(2.05? 8.28)
0.55
(0.22? 1.13)
124.99
(77.51 ? 260.19)
109.43
(61.15 ? 243.7)
15.57
(6.05 ? 31.99)
Drug use disorders 6.98
(3.87? 12.75)
0.0 0.1 3.3 2.0 0.6 0.8 5.52
(2.66? 10.82)
1.47
(0.54? 2.24)
291.52
(165.61 ? 588.06)
245.59
(124.78 ? 541.19)
45.92
(21.12 ? 72.44)
Eating disorders 0.29
(0.09? 0.53)
0.0 0.0 0.0 0.0 0.0 0.2 0.1
(0.02? 0.2)
0.19
(0.05? 0.39)
4.53
(2.04? 6.56)
1.77
(0.6 ? 2.79)
2.76
(1.07 ? 4.43)
Other mental and behavioral
disorders
0.69
(0.22? 1.23)
0.0 0.0 0.0 0.0 0.0 0.4 0.32
(0.08? 0.59)
0.37
(0.08? 0.77)
9.5
(3.94? 14.28)
5.5
(1.79 ? 8.61)
3.99
(1.36 ? 7.01)
Diabetes, urogenital, blood, and
endocrine diseases
280.14
(242.63 ? 353.84)
0.3 0.9 2.2 11.2 79.6 185.6 122.76
(103.65 ? 167.15)
157.38
(128.53 ? 205.29)
3,032.98
(2,645.05 ? 4,078.86)
1,571.2
(1,318.85 ? 2,311.61)
1,461.78
(1,239.48 ? 1,988.42)
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Table 2 Main causes of mortality and years of life lost (YLLs) by age groups and by gender, for the Spanish population in 2010 (Continued)
Diabetes mellitus 112.02
(93.98 ? 151.69)
0.0 0.0 0.2 3.9 34.7 73.3 44.69
(36.31? 64.25)
67.33
(53.47 ? 95.38)
1,146.26
(995.43 ? 1,592.83)
561.77
(479.06 ? 867.39)
584.49
(484.08 ? 889.93)
Acute glomerulonephritis 0.12
(0.06? 0.2)
0.0 0.0 0.0 0.0 0.0 <0.1 0.07
(0.03? 0.13)
0.05
(0.02? 0.1)
2.5
(1.13? 3.85)
1.55
(0.61 ? 2.75)
0.95
(0.33 ? 1.55)
Chronic kidney diseases 84.59
(67.95 ? 110.54)
0.0 0.0 0.2 2.4 21.6 60.0 40.03
(32.54? 56.18)
44.56
(30.42 ? 67.37)
819.87
(698.77 ? 1,098.83)
434.71
(369.26 ? 647.87)
385.15
(289.79 ? 590.98)
Urinary diseases and male
infertility
44.35
(26.86 ? 63.32)
0.0 0.0 0.0 1.1 10.8 32.0 21.01
(10.9? 33.29)
23.34
(11.35 ? 38.22)
422.38
(270.67 ? 566.13)
222.07
(121.63 ? 335.67)
200.31
(108.39 ? 294.38)
Gynecological diseases 0.35
(0.3 ? 0.39)
0.0 0.0 0.0 0.0 0.0 0.2 ? * 0.35
(0.3 ? 0.39)
5.16
(3.99? 6.54)
? * 5.16
(3.99 ? 6.54)
Hemoglobinopathies and
hemolytic anemia
5.12
(3.77? 7.24)
0.0 0.0 0.0 0.0 1.3 3.3 1.89
(1.27? 3.33)
3.23
(2.15? 4.79)
63.28
(49.79 ? 89.97)
28.65
(21.48 ? 47.37)
34.63
(24.75 ? 52.35)
Other endocrine, nutritional,
blood, and immune
disorders
33.6
(20.57 ? 84.45)
0.3 0.8 1.3 3.4 11.0 16.8 15.07
(7.43? 50.5)
18.52
(9.54? 47.65)
573.52
(378.68 ? 1356.21)
322.44
(178.48 ? 991.18)
251.08
(145.49 ? 542.18)
Musculoskeletal disorders 39.06
(25.64 ? 66.48)
0.0 0.0 0.3 1.5 7.9 29.3 13.39
(7.92? 29.58)
25.67
(14.36 ? 48.24)
375.55
(268.26 ? 613.79)
143.94
(96.43 ? 294.08)
231.6
(141.74 ? 414.1)
Rheumatoid arthritis 2.89
(1.98? 4.19)
0.0 0.0 0.0 0.1 1.5 1.1 0.65
(0.36? 0.91)
2.24
(1.42? 3.54)
44.56
(31.57 ? 68.08)
11.65
(6.79 ? 15.99)
32.91
(22 ? 57.69)
Other musculoskeletal
disorders
36.17
(23.93 ? 62.55)
0.0 0.0 0.2 1.3 6.5 28.2 12.74
(7.32? 28.65)
23.43
(13.07 ? 42.38)
330.99
(241.09 ? 564.59)
132.3
(86.48 ? 278.21)
198.69
(129.47 ? 310.74)
Other non-communicable
diseases
26.82
(21.12 ? 32.38)
4.9 1.3 1.1 1.7 4.1 13.7 10.76
(8.68? 13.33)
16.06
(11.32 ? 21.15)
793.69
(700.07 ? 998.5)
408.18
(349.11 ? 554.42)
385.51
(323.19 ? 522.23)
Congenital anomalies 15.23
(12.89 ? 18.32)
4.2 1.3 1.1 1.5 2.0 5.3 6.84
(5.66? 8.92)
8.38
(6.41? 10.77)
637.65
(561.04 ? 826.64)
336.37
(283.44 ? 482.44)
301.28
(254.05 ? 437.58)
Skin and subcutaneous
diseases
10.88
(6.36? 15.66)
0.0 0.0 0.0 0.0 2.2 8.4 3.53
(1.83? 5.17)
7.36
(3.26? 11.69)
94.99
(60.79 ? 124.7)
37.8
(22.51 ? 50.55)
57.19
(28.45 ? 83.86)
Sudden infant death
syndrome
0.71
(0.37? 1.3)
0.7 0.0 0.0 0.0 0.0 0.0 0.4
(0.16? 0.89)
0.31
(0.12? 0.74)
61.05
(31.43 ? 111.36)
34
(14.13 ? 76.52)
27.04
(10 ? 63.55)
Injuries 170.04
(148.35 ? 187.71)
0.3 6.1 29.5 34.1 41.7 58.4 106.22
(90.64? 120.45)
63.81
(51.39 ? 76.28)
4,467.58
(3,963.64 ? 4,986.31)
3,292.76
(2,796.78 ? 3,744.15)
1,174.82
(1,034.86 ? 1,351.47)
Transport injuries 43.13
(37.17 ? 58.97)
0.1 3.6 12.6 11.0 10.4 5.4 31.86
(25.72? 45.25)
11.27
(9.3 ? 16.49)
1,619.03
(1,392.59 ? 2,120.51)
1,251.7
(1,009.35 ? 1,695.55)
367.33
(311.6 ? 513.85)
Road injury 39.5
(34.03 ? 54.39)
0.0 3.5 11.9 9.9 9.3 4.9 28.91
(23.7? 41.92)
10.59
(8.9 ? 16.96)
1,495.72
(1,292.76 ? 1,960.84)
1,151.98
(940.51 ? 1,613.62)
343.74
(298.04 ? 519.39)
Other transport injury 3.63
(2.55? 4.38)
0.0 0.1 0.9 1.1 1.2 0.5 2.95
(1.89? 3.64)
0.68
(0.41? 0.94)
123.31
(84.2? 148.87)
99.72
(65 ? 123.8)
23.59
(13.19 ? 31.95)
Unintentional injuries other
than transport injuries
86.75
(66.99 ? 104.08)
0.2 1.5 7.1 10.1 20.6 47.2 44.43
(34.25? 53.05)
42.32
(29.03 ? 55.39)
1,528.68
(1,254.66 ? 1,728.1)
1,042.66
(815 ? 1,229.43)
486.02
(376.59 ? 575.11)
Falls 30.18
(18.17 ? 39.84)
0.0 0.1 1.5 2.9 7.5 18.0 14.31
(7.51? 19.64)
15.87
(8.02? 23.56)
447.58
(283.13 ? 557.46)
290.71
(160.9 ? 367.9)
156.87
(86.49 ? 210.64)
Drowning 6
(4.88? 7.84)
0.0 0.5 1.3 1.6 1.8 0.8 4.75
(3.71? 6.73)
1.24
(0.93? 1.72)
211.72
(171.89 ? 283.97)
174.93
(136.46 ? 247.02)
36.79
(28.15 ? 50.44)
Fire, heat, and hot
substances
3.68
(2.88? 5.15)
0.0 0.0 0.1 0.4 0.9 1.9 1.91
(1.41? 2.8)
1.78
(1.2 ? 2.94)
70.8
(57.89 ? 97.19)
45.6
(33.42 ? 69.01)
25.2
(18.93 ? 38.16)
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Table 2 Main causes of mortality and years of life lost (YLLs) by age groups and by gender, for the Spanish population in 2010 (Continued)
Poisoning 4.4
(2.11? 6.11)
0.0 0.0 1.6 1.2 0.6 0.8 2.98
(1.07? 4.44)
1.42
(0.61? 1.99)
158.83
(71.04 ? 225.89)
120.96
(40.98 ? 185.67)
37.88
(18.83 ? 49.55)
Exposure to mechanical
forces
3.13
(1.83? 4.37)
0.0 0.0 0.7 1.1 0.7 0.4 2.59
(1.37? 3.91)
0.54
(0.21? 0.84)
110.16
(64.39 ? 170.53)
97.15
(52.91 ? 157.16)
13.01
(6.3 ? 17.41)
Adverse effects of medical
treatment
9.25
(5.89? 14.86)
0.0 0.0 0.0 0.8 3.0 5.2 3.72
(2.85? 4.92)
5.53
(2.38? 11.18)
124.7
(92.38 ? 189.32)
61.82
(50.93 ? 75.98)
62.88
(32.01 ? 124.6)
Animal contact 0.23
(0.16? 0.33)
0.0 0.0 0.0 0.0 0.0 <0.1 0.17
(0.1 ? 0.25)
0.06
(0.03? 0.1)
6.95
(4.67? 10.13)
5.57
(3.3 ? 8.48)
1.38
(0.82 ? 2.26)
Unintentional injuries not
classified elsewhere
29.87
(20.72 ? 40.43)
0.1 0.1 1.4 2.2 6.0 20.1 14
(10.17? 19.39)
15.87
(7.88? 25.14)
397.93
(328.14 ? 565.3)
245.92
(194.62 ? 407.48)
152.01
(106.27 ? 205.69)
Self-harm and interpersonal
violence
40.16
(29.92 ? 51.78)
0.0 0.6 9.9 12.9 10.7 5.8 29.94
(20.81? 40.68)
10.22
(7.11? 14.48)
1,319.87
(925.79 ? 1,566.26)
998.4
(662.08 ? 1251.41)
321.47
(206.88 ? 412.94)
Self-harm 35.73
(25.84 ? 47.01)
0.0 0.5 8.2 11.5 10.0 5.4 26.91
(17.67? 37.57)
8.82
(5.95? 13.1)
1,139.19
(743.97 ? 1,364.03)
870.51
(539.56 ? 1,112.22)
268.69
(162.15 ? 360.64)
Interpersonal violence 4.43
(3.28? 6.27)
0.0 0.1 1.7 1.4 0.7 0.4 3.03
(1.99? 4.87)
1.4
(1? 1.69)
180.68
(131.92 ? 255.73)
127.9
(81.49 ? 197.53)
52.78
(36.94 ? 63.05)
Data are presented as mean values and uncertainty intervals (Lower, Upper).
Mortality ? s uncertainty intervals in the six age groups (original age groups are 20) are not included in the table and will be given upon request.
*? not applicable.
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http://www.biomedcentral.com/1741-7015/12/236diabetes, urogenital, blood, and endocrine diseases (7.8%)
(Figure 1).
As shown in Table 2, 86% of total YLLs were due
to non-communicable diseases, with injuries and com-
municable diseases accounting for 8% and 6%, res-
pectively (see specific ranking in Figure 2). In 2010,
regardless of gender, the leading specific cause for YLLs
was neoplasms followed by cardiovascular and circula-
tory diseases.
In the top twenty causes of YLLs, the ranking (% of
change between the number of YLLs) changed between
1990 and 2010 (Figure 2). Remarkably, due to a large de-
crease in the number of YLLs, cardiovascular and circu-
latory diseases dropped from the first cause in 1990 to
the second cause of YLLs in 2010 (decreased by 18%).
Neoplasms were the leading cause in 2010 (the second
in 1990), and increased almost 12% in 2010 compared to
1990. Transport injuries were the seventh cause (third in
1990), and the chronic respiratory diseases were the
third cause (fourth in 1990). Unintentional injuries other
than transport injuries were the eighth cause (fifth in
1990), and decreased by approximately 46% since 1990.
Diabetes, urogenital, blood, and endocrine diseases were
the fourth cause (sixth in 1990), increasing by almost
10%. The burden of YLLs in 2010, attributable to cir-
rhosis of the liver as well as diarrhea, lower respiratory
infections, meningitis, and other common infectious
diseases, decreased compared with 1990 (seventh to
sixth cause and eight to ninth position, respectively).
The percentage of YLLs attributable to self-harm and
interpersonal violence, neonatal disorders, other non-
communicable diseases, and HIV/AIDS and tuberculosis,
decreased by almost 9%, 32%, 35%, and 55% between 1990
and 2010, respectively. In contrast, YLLs attributable to
neurological disorders increased by 134% and were the0,0% 5
HIV/AIDS and tuberculosis
Diarrhea, lower respiratory infections, meningitis, and other? 
Neglected tropical diseases and malaria
Maternal disorders
Neonatal disorders
Nutritional deficiencies
Other communicable, maternal, neonatal, and nutritional? 
Neoplasms
Cardiovascular and circulatory diseases
Chronic respiratory diseases
Cirrhosis of the liver
Digestive diseases (except cirrhosis)
Neurological disorders
Mental and behavioral disorders
Diabetes, urogenital, blood, and endocrine diseases
Musculoskeletal disorders
Other non- communicable diseases
Injuries
Figure 1 Spanish deaths in 2010 for males (204,990 total deaths) andfifth leading cause in 2010, while YLLs due to mental and
behavioral disorders increased by 29% between 1990 and
2010 (Figure 2).
Table 3 presents all causes of DALYs and YLDs in the
Spanish population between 1990 and 2010. In this 20-
year period, there was an increase in the overall burden
of YLDs of almost 26%. In the broader classification
terms (between 1990 and 2010), musculoskeletal disor-
ders, mental and behavioral disorders, and diabetes, uro-
genital, blood, and endocrine diseases were the three
main contributors to the years lived with disability in
Spain. Focusing only in 2010, the largest contributors to
the burden of YLDs, were the musculoskeletal disorders
(26%) and the mental and behavioral disorders (22%).
The group of diabetes, urogenital, blood, and endocrine
disorders had an important contribution to the burden
of disability (10%), followed by the group of other non-
communicable disorders (9%), neurological disorders
(8%), and other unintentional injuries except for trans-
portation injuries (7%).
Putting premature mortality and disability together in
terms of DALYs provides an overall picture of the lead-
ing health problems in Spain. Between 1990 and 2010,
there was a slight increase (5.4%) in DALYs (i.e., overall
health burden) in the overall Spanish population (from
104,615.9 in 1990 to 110,269.4 in 2010). The dominant
causes of DALYs in 2010 were neoplasms, cardiovascular
and circulatory diseases, musculoskeletal disorders, men-
tal and behavioral disorders, and diabetes, urogenital,
blood, and endocrine diseases, which accounted for nearly
59% of all DALYs (Table 3).
The top five leading causes for DALYs remained simi-
lar in both 1990 and 2010, despite the decreases or in-
creases in the number of DALYs for each cause (% of
change between the numbers of DALYs). There was only,0% 10,0% 15,0% 20,0% 25,0% 30,0% 35,0% 40,0% 45,0%
Female
Male
females (200,750 total deaths) at all ages.
Figure 2 Spanish years of life lost (YLLs) ranks for the top 20 main causes in 1990 and 2010, and the percentage change between
1990 and 2010. Solid line for increase or equal position. Continuous line represents an ascending order in rank and the broken line represents a
descending order. (Δ%) = % of change in absolute numbers of DALYs.
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causes. Due to a large decrease in the number of DALYs
(11%), cardiovascular and circulatory diseases dropped
to the second cause of DALYs in 2010 and neoplasms
reached the first position increasing by 14% from 1990.
Between the sixth and the eleventh positions the causes
for DALYs changed only slightly. The transport injuries
dropped from the ninth position in 1990s to the tenth in
2010, due to a large decrease (38%) in the number of
DALYs. The neurological disorders, with a 61% increase
in DALYs, achieved the sixth position in 2010 from its
tenth position in 1990. The HIV/AIDS and tuberculosis
cause dropped one position and neonatal disorders in-
creased one position in the list of causes for DALYs for
the year 2010. Finally, the last four causes among the 20
top ranking of DALYs in Spain remained completely
stable between 1990 and 2010, despite the changes in
disability (Figure 3).
Summarizing the above data, in 2010, the leading causes
for DALYs among newborn children (0? 1 years old) were
neonatal disorders and the other communicable diseases
group. The leading causes for DALYs in the younger
group (5 to 44 years old) in the Spanish population were
mental and behavioral disorders and musculoskeletal dis-
orders, while in the middle aged and older adults groups
the leading causes shifted to cardiovascular and circula-
tory diseases and neoplasms (Figure 4).
In both 1990 and 2010, there was a high consistency
across European countries regarding the top causes ofYLDs being major depressive disorders, musculoskeletal
disorders, low back and neck pain, and diabetes, as well
as injuries (i.e., falls). YLDs caused by asthma, anxiety
disorders, and chronic obstructive pulmonary disease
ranked lower in Spain compared with other southern
European countries, in both 1990 and 2010 (Figure 5).
From 1990 to 2010 overall DALYs attributable to non-
communicable diseases in Spain increased by 897,900
from 8,626,000 to 9,523,900. When standardizing the
DALYs of 2010 to the 1990 population, the number of
DALYs which would have increased was estimated to be
1,250,900. Thus, the actual population health improved
since the demographic changes would have caused a
higher increase in DALYs than the actual 2010 DALYs.
Changes in DALYs mostly correspond to population in-
crease and are secondary to population ageing. More-
over, the highest difference was attributed to those 40
years and older.
Discussion
During the past 20 years, substantial changes have taken
place in the relative impact of burden of diseases in
Spain: while musculoskeletal disorders have increased by
28% (rank 3 as major cause of DALYs), mental and be-
havioral disorders have increased by 23% (rank 4), neu-
rological disorders by 61% (rank 6), and neoplasms by
14% (rank 1). On the other hand, cardiovascular and cir-
culatory diseases have decreased by 11% (now rank 2),
transport injuries by 38% (rank 10), and chronic
Table 3 Comparison of the main causes of disability-adjusted life years (DALYs) and years lived with disability (YLDs), in 1990 and 2010, for the Spanish
population
YLDs (hundreds) DALYs (hundreds)
1990 2010 % Δ 1990 2010 % Δ
All causes 44,316.8 55,706.6 25.7% 104,615.9 110,269.4 5.4%
Communicable, maternal, neonatal, and
nutritional disorders
1,914.7 (1,415.3 ? 2,628.9) 1,942.5 (1,377.8? 2,767.8) 1% 6,394.8 (5,773.6? 7,126) 5,067.4 (4,450.8? 5,848.2) −21%
HIV/AIDS and tuberculosis 285.4 (202.5? 384.5) 183 (128.5 ? 248.3) −36% 1,532.1 (1,356.2? 1,720.5) 738.3 (643.6 ? 844.3) −52%
Tuberculosis 114.8 (71.7? 171.8) 84.4 (50.8 ? 129.2) −26% 340.6 (274? 409.3) 175.9 (136.8 ? 230.7) −48%
HIV/AIDS 170.6 (123.2? 223.1) 98.6 (70.8 ? 131.4) −42% 1,191.6 (1,042? 1,360.4) 562.4 (478.8 ? 651.9) −53%
HIV disease resulting in mycobacterial infection 12.1 (6.7? 19.4) 4.7 (2? 8.3) −62% 59.8 (51.5? 69.1) 19.6 (16 ? 24.1) −67%
HIV disease resulting in other specified or
unspecified diseases
158.4 (114.2? 206.7) 93.9 (67.9 ? 125.4) −41% 1,131.7 (993.6? 1,271.3) 542.8 (469.8 ? 629.4) −52%
Diarrhea, lower respiratory infections, meningitis, and
other common infectious diseases
858.5 (590.7? 1249) 925.1 (621.7? 1339.5) 8% 2,555.5 (2,206.4? 3,004.8) 2,358.1 (1,992.4? 2,814.4) −8%
Diarrheal diseases 306.2 (201.3? 440.4) 363.2 (238.6? 520.2) 19% 358.6 (252.5? 493.1) 428.9 (305.6 ? 585.7) 20%
Typhoid and paratyphoid fevers 0 (0? 0.1) 0 (0? 0.1) 27% 1.1 (0.1? 2) 1 (0.1? 2) −4%
Lower respiratory infections 44.3 (29.7? 62) 48.4 (33 ? 66.8) 9% 1391.6 (1227.5? 1612.5) 1,275.9 (1,096? 1,523.9) −8%
Upper respiratory infections 219.3 (106.2? 390.9) 227.8 (110.9? 429.7) 4% 221 (107.8? 392.7) 228.4 (111.5 ? 430.3) 3%
Otitis media 211.6 (127.1? 339.9) 211.9 (120.7? 361) 0.2% 213.6 (127.9? 341.7) 213.3 (123? 363.3) 0%
Meningitis 52.1 (33.7? 77.9) 46.8 (29 ? 71.8) −10% 261.9 (229.8 ? 309) 153.7 (129.1 ? 183.3) −41%
Pneumococcal meningitis 10.2 (6.2? 15.4) 6.7 (3.8? 10.6) −34% 39.8 (33.2? 47.3) 21.8 (17.6 ? 26.7) −45%
H influenza type B meningitis 7.4 (4.3? 11.8) 3.1 (1.6? 5.1) −58% 33.7 (27.2? 42.1) 13.6 (10.8 ? 17.3) −60%
Meningococcal infection 16.6 (10.2? 25.7) 14.6 (8.4? 23.2) −12% 88.8 (75.5? 106.7) 50.1 (40.9 ? 61.3) −44%
Other meningitis 17.2 (10.9? 26.6) 21.8 (13.3 ? 33.6) 27% 99 (86 ? 116.3) 67.7 (55.6 ? 82.7) −32%
Encephalitis 5.6 (3.3? 8.7) 5.5 (3.2? 9) −1% 28.5 (24.7? 32.7) 17.9 (14.7 ? 21.8) −37%
Diphtheria 0 (0? 0) 0 (0? 0) −82% 0.9 (0? 7.3) 0.3 (0? 2.5) −66%
Whooping cough 2.4 (1.3? 3.8) 0.6 (0.3? 1.1) −74% 47.8 (2.3? 221.4) 9.3 (0.6? 40.9) −81%
Tetanus 0 (0? 0) 0 (0? 0) −69% 3.4 (0.4? 13) 0.7 (0.1? 2.6) −80%
Measles 0.8 (0.3? 1.4) 0 (0? 0.1) −99% 4 (2.2? 6.4) 1.5 (0.7? 3.9) −62%
Varicella 16.2 (8.2? 29.1) 20.8 (10.1 ? 39.2) 29% 23.3 (9.2? 63.2) 27.3 (11.6 ? 67.5) 18%
Neglected tropical diseases and malaria 8.5 (2.3? 21.8) 15.6 (2.5? 51.2) 83% 69.6 (39.7? 120.3) 64.9 (35.1 ? 120.1) −7%
Malaria 0.5 (0? 3.9) 0.1 (0? 0.8) −75% 0.5 (0? 3.9) 0.1 (0? 0.8) −75%
Leishmaniasis 1.3 (0.6? 2.7) 1.4 (0.6? 2.9) 6% 10.6 (7.4? 14.7) 8.4 (5.8? 11.5) −21%
*Cysticercosis 0 (0? 0) ? * ? * 0.6 (0? 2.2) ? * ? *
Echinococcosis 5.3 (0.8? 18.1) 7 (1? 25.6) 32% 15.6 (2.2? 47.7) 12.1 (2.1? 35.5) −22%
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Table 3 Comparison of the main causes of disability-adjusted life years (DALYs) and years lived with disability (YLDs), in 1990 and 2010, for the Spanish
population (Continued)
Dengue 0 (0? 0) 0 (0? 0) ? * 31.8 (9.6? 70.5) 30.9 (12.5 ? 68.8) −3%
Rabies 0 (0? 0) 0 (0? 0) 13% 5.6 (2.7? 12.4) 2 (1.1? 3.9) −64%
Food-borne trematodiases 0.1 (0? 0.4) 0.1 (0? 0.3) −31% 0.1 (0? 0.4) 0.1 (0? 0.3) −31%
Other neglected tropical diseases 1.3 (0.1? 1.6) 7 (0.2? 6.2) 425% 4.8 (2.5? 7) 11.3 (3? 11.7) 133%
Maternal disorders 14.1 (8.9? 21.7) 12.5 (7.5? 19.6) −11% 37 (29 ? 47.5) 28.7 (21.7 ? 37.2) −22%
Maternal hemorrhage 5.9 (3.4? 9.5) 5.3 (3? 8.5) −11% 10.3 (7.4? 14) 8.5 (6? 11.9) −17%
Maternal sepsis 0.3 (0? 1) 0.3 (0? 1) −9% 1.3 (0.8? 2.1) 0.9 (0.5? 1.6) −33%
Hypertensive disorders of pregnancy 0.6 (0.3? 1.1) 0.7 (0.3? 1.2) 9% 3.9 (3? 5.1) 2.9 (2.1? 3.8) −26%
Obstructed labor 1.1 (0? 3.4) 1.1 (0? 3.4) −2% 2 (0.9? 4.3) 1.8 (0.7? 4.2) −12%
Abortion 2 (1.1? 3.4) 1.4 (0.7? 2.5) −29% 5.2 (3.9? 6.8) 3.4 (2.4? 4.6) −35%
Other maternal disorders 4.1 (2.6? 6.2) 3.8 (2.3? 5.8) −8% 14.2 (11.1? 18.1) 11.3 (8.4? 14.4) −21%
Neonatal disorders 224.6 (164.9? 300.8) 218.4 (162.3? 282.8) −3% 1,468.3 (1,242.3? 1,668.6) 1,061.2 (934.7? 1,183) −28%
Preterm birth complications 96.4 (66.9? 136.9) 109.4 (75.9? 149.6) 13% 788.4 (627.9? 938.5) 533 (433? 665.9) −32%
Neonatal encephalopathy (birth asphyxia and
birth trauma)
126.6 (89.5 ? 172.7) 107 (77.3? 143.6) −15% 425.4 (336.5 ? 527.3) 297.5 (235.6 ? 375) −30%
Sepsis and other infectious disorders of the
newborn baby
0.1 (0.1? 0.3) 0.3 (0.2? 0.6) 140% 110.1 (60.9 ? 192.3) 111.2 (60? 197.5) 1%
Other neonatal disorders 1.4 (1? 2) 1.7 (1.2? 2.3) 16% 144.3 (91.2 ? 262.3) 119.5 (67.1? 179.2) −17%
Nutritional deficiencies 444.6 (269.2? 712.5) 507.8 (314.2? 801.1) 14% 524.2 (347? 797.2) 590.7 (394.4 ? 885) 13%
Protein-energy malnutrition 14.3 (9.3? 21.2) 22.7 (14.8 ? 31.8) 59% 46.2 (38.5? 57.6) 75 (52.4 ? 93.8) 62%
Iodine deficiency 427.1 (251.8? 694) 480.5 (285? 763.7) 13% 428.8 (253.7? 695.7) 482.4 (286.9 ? 765.8) 13%
Iron-deficiency anemia 1.1 (0.5? 2) 3 (1? 3.2) 171% 41.8 (35.4? 54.5) 27.9 (16.9 ? 33.7) −33%
Other nutritional deficiencies 2.2 (1.8? 2.8) 1.5 (0.9? 2) −29% 7.5 (6.3? 9.8) 5.3 (3.2? 6.9) −29%
Other communicable, maternal, neonatal, and
nutritional disorders
79 (38.7 ? 149.3) 80.1 (35.6 ? 168.3) 1% 208 (161.6? 281.2) 225.5 (162.4 ? 323.7) 8%
Sexually transmitted diseases excluding HIV 64.3 (29.6? 128.4) 56.9 (26 ? 114) −11% 91.6 (56.3? 157.8) 66.6 (35.2 ? 123.7) −27%
Syphilis 3.9 (0.2? 8.7) 4.8 (0.3? 10.7) 21% 25.4 (15.7? 39.3) 10.9 (5? 18) −57%
Sexually transmitted chlamydial diseases 25.3 (8.7? 60) 22.4 (7.6? 53.6) −12% 26.7 (10.1? 61.5) 23.2 (8.3? 54.3) −13%
Gonococcal infection 13.7 (5.2? 30.2) 14.5 (5? 32.7) 6% 14.8 (6.1? 31.3) 15.1 (5.6? 33.5) 2%
Trichomoniasis 13.3 (0.1? 41.8) 9.2 (0.1? 29.1) −31% 13.3 (0.1? 41.8) 9.2 (0.1? 29.1) −31%
Other sexually transmitted diseases 8 (2.9? 18.1) 6 (2.5? 12) −25% 11.5 (6.2? 21.5) 8.2 (4.5? 14.2) −29%
Hepatitis 12.2 (6? 21.9) 12.9 (6.2? 22.8) 6% 67.3 (57.9? 79) 66 (55.8 ? 77.8) −2%
Acute hepatitis A 8.3 (3.9? 14.7) 7.5 (3.7? 13) −9% 17 (11.2 ? 24.8) 11 (6.5? 17.6) −35%
Acute hepatitis B 2.8 (0.2? 9.2) 3.4 (0.2? 10.6) 21% 42.8 (26.3? 55.3) 24 (12.6 ? 43.4) −44%
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Table 3 Comparison of the main causes of disability-adjusted life years (DALYs) and years lived with disability (YLDs), in 1990 and 2010, for the Spanish
population (Continued)
Acute hepatitis C 1 (0.2? 2.1) 2 (0.4? 4.1) 87% 7.6 (2.8? 15.8) 31 (10.5 ? 53.4) 308%
Leprosy 0.1 (0? 0.1) 0 (0? 0) −87% 0.1 (0? 0.1) 0 (0? 0) −87%
Other infectious diseases 2.5 (0? 0.3) 10.3 (0? 0.4) 314% 49 (37.6 ? 81.3) 92.8 (39.3 ? 114.7) 89%
Non-communicable diseases 38,528.9 (32,278.2? 45,503.6) 48,269.1 (40,257.6? 56,616.6) 25% 86,260 (79,823.1? 93,301.2) 95,239.4 (87,522.2? 10,3475.6) 10%
Neoplasms 474.2 (349.1? 630.6) 816.4 (597.6? 1074.5) 72% 16,917.3 (16,102.7? 17,858.3) 19,304.5 (18,003? 20,302.6) 14%
Esophageal cancer 3.2 (1.6? 5.3) 3.6 (1.8? 6.2) 10% 413.9 (310.3? 535.2) 392.1 (290.6 ? 538.8) −5%
Stomach cancer 24.3 (15.3? 35.6) 21.2 (12.9 ? 33) −13% 1,443.2 (1,131? 1,931.8) 1,007.9 (765? 1,402.6) −30%
Liver cancer 6.5 (3.9? 9.8) 9.6 (5.8? 14.8) 47% 720 (581.5? 818.5) 846.8 (712.5 ? 1,044.6) 18%
Liver cancer secondary to hepatitis B 0.9 (0.3? 1.8) 1.3 (0.4? 2.4) 38% 100.9 (80.1 ? 116.3) 119.2 (97.8? 152.4) 18%
Liver cancer secondary to hepatitis C 2.8 (1.5? 4.7) 3.9 (2? 6.6) 40% 287.9 (236.3? 332.2) 331.9 (277.3 ? 427.1) 15%
Liver cancer secondary to alcohol use 2.2 (1.1? 3.7) 3.6 (1.9? 5.9) 64% 253 (201.7? 291.3) 301 (253? 381) 19%
Other liver cancer 0.6 (0.1? 1.4) 0.8 (0.1? 1.6) 26% 78.2 (62.9? 90.4) 94.7 (74.6 ? 116.3) 21%
Larynx cancer 14 (7.3? 24.9) 12.3 (6.5? 23.3) −12% 498.7 (252.2 ? 859.6) 373.9 (202.3 ? 685.2) −25%
Trachea, bronchus, and lung cancers 34.1 (22.3? 49.5) 45.5 (25.9 ? 64.2) 34% 3,138.8 (2,541.8? 3,982.3) 3,686.7 (2,408.1? 4,161.1) 17%
Breast cancer 122.7 (80.8 ? 187.9) 188.1 (120.8? 277.2) 53% 1,496.8 (1,400.8? 1,611.5) 1,469.4 (1,340.6? 1,619.2) −2%
Cervical cancer 5.4 (2.9? 8.7) 5.2 (2.7? 8.6) −4% 226.8 (143.3 ? 321.6) 212.3 (135.6 ? 306.1) −6%
Uterine cancer 10.9 (5.7? 20.1) 13.6 (5.7? 23.1) 24% 174.1 (100.8? 316.1) 194.6 (93.5? 271.9) 12%
Prostate cancer 40.2 (27 ? 60) 120.3 (78.9? 185.9) 199% 609 (373.5? 941.4) 939.3 (572.7 ? 1,489.8) 54%
Colon and rectum cancers 63.1 (44.8? 85.4) 128.7 (90.3? 171.7) 104% 1,675.7 (1,476.6? 1,895.5) 2,452.4 (2,019.5? 2,711) 46%
Mouth cancer 12.4 (8.2? 17.8) 13.8 (8.9? 20.3) 12% 307.3 (257.8? 337.4) 296.6 (250.1 ? 367.2) −3%
Nasopharynx cancer 0.9 (0.3? 1.9) 1 (0.3? 2) 5% 70.2 (40.1? 94.4) 63.2 (40.4 ? 88.2) −10%
Cancer of other part of pharynx and oropharynx 4.1 (2 ? 7) 5.8 (2.8? 9.4) 42% 172.5 (100.3? 251.3) 211.9 (125.8 ? 299.5) 23%
Gallbladder and biliary tract cancer 3.6 (1.9? 6.1) 5.1 (2.5? 9) 41% 253.9 (169.6? 370.5) 274.3 (193? 414.1) 8%
Pancreatic cancer 3.9 (2? 6.5) 6.3 (3.4? 10.4) 63% 627.8 (480.8? 812.9) 881.8 (646.5 ? 1120.7) 40%
Malignant melanoma of skin 4.2 (2.3? 7.9) 8.6 (4.7? 13.7) 103% 140.1 (94.4 ? 223.2) 207.1 (133? 294.9) 48%
Non-melanoma skin cancer 15.6 (10.7? 21.9) 38 (25.9 ? 52.8) 143% 89.4 (55.1? 125.3) 110.9 (80.5? 165.1) 24%
Ovarian cancer 6.2 (3.6? 9.8) 9.4 (5.2? 14.5) 52% 336.7 (252.6? 453.1) 425.2 (287.4 ? 561.8) 26%
Testicular cancer 0.8 (0.2? 1.6) 1.4 (0.5? 2.9) 86% 22.9 (13.7? 34.8) 22.7 (12.9 ? 32.9) −1%
Kidney and other urinary organ cancers 5.6 (3.1? 8.6) 17.7 (10.2 ? 30.6) 218% 255.5 (178.9? 327.2) 592.6 (435.2 ? 958.7) 132%
Bladder cancer 31.7 (21.7? 43.9) 49.8 (32.2 ? 69.6) 57% 617 (491.5? 789.2) 704.1 (508.2 ? 824.7) 14%
Brain and nervous system cancers 11.5 (6.6? 17.9) 17.4 (8.7? 27.2) 51% 716.6 (488.1? 1,011.1) 848.3 (492.4 ? 1,050.7) 18%
Thyroid cancer 2.5 (1.3? 4.4) 4.1 (2.2? 6.8) 63% 51.9 (40.5? 66.8) 61.5 (45.7 ? 78.9) 18%
Hodgkin? s disease 2.4 (1? 4.2) 2.1 (0.9? 3.9) −11% 112.8 (73.1 ? 166.8) 72.3 (47.9 ? 109.7) −36%
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Table 3 Comparison of the main causes of disability-adjusted life years (DALYs) and years lived with disability (YLDs), in 1990 and 2010, for the Spanish
population (Continued)
Non-Hodgkin ? s lymphoma 9.4 (6? 13.8) 16.1 (10 ? 23.9) 72% 417.3 (366.4? 493.7) 503.5 (364.3 ? 578.3) 21%
Multiple myeloma 5.4 (2.8? 9) 8.3 (4.3? 13.5) 55% 212.7 (146.8? 305.2) 275.6 (182.9 ? 388.8) 30%
Leukemia 10.4 (6.7? 15.4) 16.1 (10 ? 23.5) 55% 705.9 (575.5? 880) 688.4 (544.1 ? 817) −2%
Other neoplasms 19.2 (12.4? 28.5) 47.2 (30 ? 69.8) 145% 1,409.8 (1,108.1? 1,845.1) 1,489.3 (1,190.5? 2,016.9) 6%
Cardiovascular and circulatory diseases 1,911.6 (1,475.9 ? 2,423) 2,864.9 (2,268.9? 3,499.4) 50% 20,076.7 (18,998.5? 20,904.2) 17,802 (16,834.2? 19,181.8) −11%
Rheumatic heart disease 125.4 (77.4 ? 198.2) 139.1 (93.2? 207.5) 11% 823.4 (745.2? 933.8) 507.3 (429.5 ? 599) −38%
Ischemic heart disease 737.6 (477.9? 1108) 974.8 (636? 1420.7) 32% 9,202.7 (8,705.1? 9,952.4) 8,055.8 (7,462.7? 8,876.3) −12%
Cerebrovascular disease 337.1 (278.1? 393.5) 640.5 (529.3? 755.2) 90% 6,437.3 (5,648.1? 6,783.7) 4,752.8 (4,252.9? 5,829.1) −26%
Ischemic stroke 271.4 (225? 318.7) 515.9 (426.9? 609.4) 90% 4,130.9 (3,546.5? 4,389.3) 3,011 (2,635.2? 4,183.6) −27%
Hemorrhagic and other non-ischemic stroke 65.6 (54.3? 77.7) 124.6 (102.1? 147.8) 90% 2,306.5 (2,058.8? 2,601.6) 1,741.8 (1,502.3? 1,936) −24%
Hypertensive heart disease 28.3 (17.3? 42.8) 46.5 (28.8 ? 71.4) 65% 531.9 (432.3? 671.4) 613 (490.4 ? 764.1) 15%
Cardiomyopathy and myocarditis 17.5 (10.3? 27.4) 26.6 (16.3 ? 40.9) 52% 537.7 (496.6? 569.2) 723.9 (634? 857.1) 35%
Atrial fibrillation and flutter 278.3 (186.1? 398) 460.9 (306.5? 658) 66% 363.2 (269.6? 484.1) 849.2 (631.8 ? 1127.7) 134%
Aortic aneurysm 0 (0? 0) 0 (0? 0) ? * 261.2 (199.7? 339.1) 308.2 (224.6 ? 403.1) 18%
Peripheral vascular disease 39.5 (20.1? 70.8) 60.7 (30.8 ? 109.7) 54% 83.5 (54.6? 124.9) 174.6 (116.3 ? 253.8) 109%
Endocarditis 4.2 (2.4? 6.8) 7.4 (4.5? 11.6) 75% 74.6 (64 ? 86.9) 76.3 (59.9 ? 88) 2%
Other cardiovascular and circulatory diseases 343.8 (182.1? 561.1) 508.7 (275.7? 807.5) 48% 1,761.1 (1,592.8? 1,992.2) 1,740.9 (1,496.8? 2,046.5) −1%
Chronic respiratory diseases 1,935.1 (1,247? 2,764.6) 22,17.7 (14,39.4? 31,23.6) 15% 5,623.2 (4,907.3? 6,436.1) 5,260.3 (4,434.9? 6,184.9) −6%
Chronic obstructive pulmonary disease 860.7 (5,23.1? 1,276.8) 10,99.1 (683? 15,94.7) 28% 3,030.1 (2,586.4? 3,515.9) 2,916 (2,423.7? 3,483.1) −4%
Pneumoconiosis 8.3 (5.3? 12) 15.9 (10 ? 23.7) 92% 195.7 (134.5? 283) 158.8 (112.5 ? 223.2) −19%
Asthma 749.4 (411.4? 1,203.2) 791.4 (443? 1,253.1) 6% 969.4 (632.4? 1423.6) 917.8 (564.5 ? 1377.3) −5%
Interstitial lung disease and pulmonary sarcoidosis 8.9 (5.9? 13.3) 16.1 (10.4 ? 24.3) 81% 158.8 (118.1? 251.5) 262.6 (181.8 ? 373) 65%
Other chronic respiratory diseases 307.9 (187? 458.9) 295.2 (183.7? 431.1) −4% 1,269.2 (988? 1,483.8) 1,005.2 (819.7? 1,264) −21%
Cirrhosis of the liver 34.4 (21.9? 49.6) 37.6 (24.3 ? 54) 9% 2,358.1 (1,931.4? 2,609.8) 1,772.7 (1585.9? 2,231.2) −25%
Cirrhosis of the liver secondary to hepatitis B 1.3 (0.5? 2.5) 1.3 (0.5? 2.6) 4% 89.4 (70.2? 105.5) 67.9 (57 ? 86.1) −24%
Cirrhosis of the liver secondary to hepatitis C 13.2 (7.4? 21.5) 14.4 (7.7? 23.3) 9% 895 (711.6? 1049.2) 687.1 (582? 870.4) −23%
Cirrhosis of the liver secondary to alcohol use 15.8 (8.9? 25) 17.5 (9.9? 28.4) 11% 1,105.7 (847.2? 1295.5) 830.5 (694.9 ? 1,084.7) −25%
Other cirrhosis of the liver 4.1 (2? 6.9) 4.3 (2.1? 7.6) 4% 268 (211.1? 313.4) 187.2 (156.9 ? 238.2) −30%
Digestive diseases (except cirrhosis) 423.2 (248.1? 730.7) 492.4 (313.7? 755.8) 16% 1,683 (1,452.6? 2,012.8) 1,860 (1,610.1? 2,164.5) 11%
Peptic ulcer disease 34 (17.9 ? 64.8) 21.8 (11 ? 46.2) −36% 251.8 (202.3 ? 293.9) 116.2 (95? 164.7) −54%
Gastritis and duodenitis 29.9 (19.3? 44.6) 38.8 (25.8 ? 56.3) 30% 46.9 (33.4? 62.6) 46.5 (32.1 ? 65) −1%
Appendicitis 7.8 (2.8? 16.7) 8.3 (3? 17.8) 6% 43.7 (30.9? 65.7) 37.7 (22.8 ? 52.5) −14%
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Table 3 Comparison of the main causes of disability-adjusted life years (DALYs) and years lived with disability (YLDs), in 1990 and 2010, for the Spanish
population (Continued)
Paralytic ileus and intestinal obstruction
without hernia
0.6 (0? 2.7) 0.6 (0? 2.6) 3% 123.3 (96.4 ? 175.4) 169.4 (106.6 ? 226.9) 37%
Inguinal or femoral hernia 28.3 (6.6? 84) 28.9 (5.7? 81.8) 2% 55.8 (33.9? 110.3) 48.7 (25.4 ? 101.4) −13%
Non-infective inflammatory bowel disease 205.8 (88.9 ? 434.4) 214.3 (109.5? 390.4) 4% 243.3 (127.2? 473.9) 257 (151.9 ? 435.7) 6%
Vascular disorders of intestine 1 (0.2? 2.4) 1.6 (0.3? 3.9) 70% 232.9 (117.1? 468.5) 313.5 (166? 604) 35%
Gall bladder and bile duct disease 36.4 (24.5? 51.6) 45.6 (30.7 ? 64.3) 25% 189.2 (161.3? 229.6) 207.8 (164.8 ? 260.5) 10%
Pancreatitis 16.3 (5.8? 38.3) 37.2 (12.8 ? 83.9) 128% 224.4 (164.8? 275.8) 228.1 (177? 303.9) 2%
Other digestive diseases 63.2 (37 ? 108.4) 95.3 (60.6 ? 146.9) 51% 271.7 (228? 356.4) 435.1 (337.6 ? 529.1) 60%
Neurological disorders 3,407 (2,631.9? 4,321.9) 4,627.9 (3,616.3? 5,804.5) 36% 4,581 (3,789.1? 5,481.9) 7,372.4 (6,127.5? 8,666.4) 61%
Alzheimer's disease and other dementias 858.3 (612.7? 1,136) 1,640.7 (1,185? 2,196.8) 91% 1,433.9 (1,138.4? 1,754.3) 3,518 (,2707.8? 4,334.5) 145%
Parkinson's disease 71.8 (46 ? 114.3) 115.7 (72.9? 189) 61% 230.4 (180.8? 300.8) 390 (290.8 ? 496.1) 69%
Epilepsy 292 (215.3 ? 381.1) 324 (242.9 ? 425.2) 11% 399.4 (320.1? 491.9) 432.1 (343? 538.1) 8%
Multiple sclerosis 37.7 (26.5? 51) 54.5 (37.3 ? 74.1) 45% 82.1 (67.6? 98.9) 109 (86.3? 133.8) 33%
Migraine 1,893.5 (1,198.1 ? 2,731.1) 2,146 (1,339.7? 3,101.9) 13% 1893.5 (1198.1? 2731.1) 2146 (1339.7? 3101.9) 13%
Tension-type headache 117.1 (65.8 ? 188) 144.1 (82.7? 233.9) 23% 117.1 (65.8 ? 188) 144.1 (82.7? 233.9) 23%
Other neurological disorders 136.7 (102.7? 176.2) 202.8 (153.7? 261.7) 48% 424.5 (336.1? 567.1) 633.1 (480.2 ? 802.4) 49%
Mental and behavioral disorders 10,177.2 (8,247.3? 12,325.7) 12,464.1 (10,170.8? 15,032.3) 22% 10,528.7 (8,600.5? 12,716.4) 12,917.2 (10,630.6? 15,432.4) 23%
Schizophrenia 771.1 (443.1? 1,144.3) 1,052.2 (583.9? 1,591.4) 36% 781.6 (453.6? 1,153.9) 1,074.7 (606.8? 1,614.1) 37%
Alcohol use disorders 691 (381.2? 1156.4) 757.1 (401.2? 1,235.8) 10% 797 (482.4? 1,257.7) 882.1 (514.8 ? 1,385.4) 11%
Drug use disorders 1,644.7 (1,176.5 ? 2,156.1) 1,784.5 (1,277.6? 2,334.5) 9% 1,873.5 (1,391? 2,416.5) 2,076 (1,536.1? 2,677.5) 11%
Opioid use disorders 746.5 (502.9? 1003.1) 844.4 (571.9? 1,134.8) 13% 886.9 (629.1? 1,165.1) 1,016.2 (728.8? 1,339.5) 15%
Cocaine use disorders 195.6 (112.9? 306.5) 216.7 (124.3? 335) 11% 199.3 (117.2? 313.6) 218.6 (124.8 ? 338.9) 10%
Amphetamine use disorders 155.2 (86.9 ? 249.2) 162.1 (91.4? 255.5) 4% 157.2 (88.8 ? 251.8) 164.5 (92.3? 262.9) 5%
Cannabis use disorders 213.6 (107.1? 377.3) 201.5 (100.3? 367.1) −6% 213.6 (107.1 ? 377.3) 201.5 (100.3 ? 367.1) −6%
Other drug use disorders 333.8 (205.6? 499.4) 359.8 (226.7? 523.5) 8% 416.4 (280.9? 592.2) 475.1 (327? 669.2) 14%
Unipolar depressive disorders 4,011.1 (2,829.7 ? 5,395.6) 5,308.1 (3,910.9? 7,025.8) 32% 4,011.1 (2,829.7? 5,395.6) 5,308.1 (3,910.9? 7,025.8) 32%
Major depressive disorder 3,352.4 (2,332.1 ? 4,626.6) 4,521.8 (3,227.7? 6,093.6) 35% 3,352.4 (2,332.1? 4,626.6) 4,521.8 (3,227.7? 6,093.6) 35%
Dysthymia 658.7 (426.3? 922.7) 786.3 (508.1? 1,094.9) 19% 658.7 (426.3? 922.7) 786.3 (508.1 ? 1,094.9) 19%
Bipolar affective disorder 696.1 (425.1? 1051) 835.3 (510.6? 1,251.2) 20% 696.1 (425.1? 1051) 835.3 (510.6 ? 1251.2) 20%
Anxiety disorders 1,213.6 (826.9? 1,673.9) 1331.1 (906.8 ? 1,856.4) 10% 1,213.6 (826.9? 1,673.9) 1,331.1 (906.8? 1,856.4) 10%
Eating disorders 296.4 (171.5? 476.8) 570.1 (334.2? 924.9) 92% 298.7 (174.6? 479.3) 574.6 (339.7 ? 929.5) 92%
Pervasive development disorders 399.8 (269.4? 578.2) 452.2 (302.8? 648.9) 13% 399.8 (269.4? 578.2) 452.2 (302.8 ? 648.9) 13%
Autism 188.8 (122.7? 275.7) 216.3 (140.4? 317.6) 15% 188.8 (122.7? 275.7) 216.3 (140.4 ? 317.6) 15%
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Table 3 Comparison of the main causes of disability-adjusted life years (DALYs) and years lived with disability (YLDs), in 1990 and 2010, for the Spanish
population (Continued)
Asperger? s syndrome 211.1 (134.8? 319.5) 235.8 (154.4? 352.7) 12% 211.1 (134.8? 319.5) 235.8 (154.4 ? 352.7) 12%
Childhood behavioral disorders 291.8 (171.3? 450.9) 209.7 (120.2? 323.4) −28% 291.8 (171.3 ? 450.9) 209.7 (120.2 ? 323.4) −28%
Attention-deficit hyperactivity disorder 27 (15.2? 43.6) 20.8 (11.8 ? 33.8) −23% 27 (15.2 ? 43.6) 20.8 (11.8 ? 33.8) −23%
Conduct disorder 264.7 (151? 419.6) 188.9 (105? 299.2) −29% 264.7 (151? 419.6) 188.9 (105? 299.2) −29%
Idiopathic intellectual disability 92 (53.5? 142.5) 74.1 (38 ? 123.4) −19% 92 (53.5 ? 142.5) 74.1 (38 ? 123.4) −19%
Other mental and behavioral disorders 69.5 (41 ? 108.2) 89.7 (52 ? 143.5) 29% 73.4 (44.8? 112.2) 99.2 (60.1 ? 152.2) 35%
Diabetes, urogenital, blood, and endocrine diseases 4,245.7 (3,050.2 ? 5,693.7) 5,381.9 (3,956.8? 7,145.9) 27% 7,013.4 (5,814.5? 8,532.3) 8,414.8 (6,968.8? 1,0395.6) 20%
Diabetes mellitus 2,207.8 (1461.1? 3173) 2,807.9 (1,906.5? 4,022.5) 27% 3,490.7 (2,731.4? 4,487.2) 3,954.2 (3,014.9? 5,187.7) 13%
Acute glomerulonephritis 0 (0? 0.1) 0 (0? 0) −9% 3.8 (2.4? 6.7) 2.5 (1.1? 3.9) −34%
Chronic kidney diseases 537.1 (370.6? 805.8) 770.3 (538.4? 1101) 43% 1,371.7 (1,146.5? 1,649.9) 1,590.2 (1,313.1? 1,967.6) 16%
Chronic kidney disease due to diabetes mellitus 80.8 (52.9? 117.2) 119.3 (78.1? 172.1) 48% 214.8 (173.7? 261.2) 242 (190.6 ? 308.7) 13%
Chronic kidney disease due to hypertension 99.2 (66.2? 147.1) 143.9 (97.4? 204.3) 45% 264.7 (219.2? 322.4) 315.3 (257.2 ? 393.6) 19%
Chronic kidney disease unspecified 357.1 (240.4? 547.6) 507.1 (352.2? 735) 42% 892.2 (740.5? 1101.4) 1,032.9 (841.5? 1,303.6) 16%
Urinary diseases and male infertility 395.5 (254.4? 603.1) 541.2 (347.1? 812.7) 37% 604.2 (451.8? 809.5) 963.5 (717.5 ? 1,265.4) 59%
Tubulointerstitial nephritis, pyelonephritis, and
urinary tract infections
5.9 (2.6? 11.2) 7.4 (3.5? 14.3) 27% 156.5 (124.4? 229.1) 328.8 (177.1 ? 474.9) 110%
Urolithiasis 50 (27.3 ? 81.3) 72.6 (40.1 ? 114.7) 45% 59.1 (36 ? 91.8) 78.8 (46.4 ? 122.1) 33%
Benign prostatic hyperplasia 319.6 (201.5? 487.1) 431.8 (270.1? 654.1) 35% 319.6 (201.5? 487.1) 431.8 (270.1 ? 654.1) 35%
Male infertility 3.2 (1.2? 7.1) 4.2 (1.6? 9) 32% 3.2 (1.2? 7.1) 4.2 (1.6? 9) 32%
Other urinary diseases 16.9 (9.5? 27.4) 25.1 (14.1 ? 40.3) 49% 65.9 (51.6? 86) 119.8 (87.9? 155.5) 82%
Gynecological diseases 464.2 (258.8? 797) 585.2 (325.2? 999) 26% 468.9 (263.7? 801.4) 590.4 (330? 1,004) 26%
Uterine fibroids 96.8 (43.5? 190.7) 139.2 (60.2? 268.9) 44% 97.2 (43.9? 191.1) 139.7 (60.8? 269.4) 44%
Polycystic ovarian syndrome 142.4 (66.4 ? 265.2) 170.3 (77.9? 324.2) 20% 142.4 (66.4 ? 265.2) 170.3 (77.9? 324.2) 20%
Female infertility 2.5 (0.9? 5.4) 3.1 (1.1? 6.7) 24% 2.5 (0.9? 5.4) 3.1 (1.1? 6.7) 24%
Endometriosis 27.1 (9? 52.7) 34.3 (12.4 ? 66.5) 27% 27.1 (9? 52.7) 34.3 (12.4 ? 66.5) 27%
Genital prolapse 123.8 (49.5 ? 259.5) 156.3 (62.6? 339.3) 26% 124.2 (49.9 ? 259.9) 156.7 (63? 339.7) 26%
Premenstrual syndrome 71.7 (0? 200.2) 82.1 (0? 213.6) 14% 71.7 (0? 200.2) 82.1 (0? 213.6) 14%
Other gynecological diseases 0 (0? 0) 0 (0? 0) ? * 3.9 (3.4? 4.6) 4.2 (3.3? 5.4) 10%
Hemoglobinopathies and hemolytic anemia 498.7 (296.2? 1080.4) 477.4 (291.8? 935) −4% 599.4 (393.7 ? 1,169.3) 540.7 (350.5 ? 997.4) −10%
Thalassemia 161.4 (102.1? 247.1) 156.1 (99.3? 254.6) −3% 174.9 (115.5 ? 260.7) 162.3 (105.8 ? 260.9) −7%
Sickle cell disorders 309.9 (171.6? 832.4) 296.2 (172.1? 703.8) −4% 338.4 (199.5 ? 859.6) 309.3 (184.8 ? 715.3) −9%
G6PD deficiency 24.8 (11.7? 93.6) 18.3 (9.3? 58.9) −26% 32.5 (19 ? 101.1) 22.5 (13.2 ? 62.6) −31%
Other hemoglobinopathies and hemolytic anemia 2.5 (0.5? 1.8) 6.7 (0.9? 9.3) 169% 53.6 (36.2? 64.7) 46.6 (31.4 ? 79.2) −13%
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Table 3 Comparison of the main causes of disability-adjusted life years (DALYs) and years lived with disability (YLDs), in 1990 and 2010, for the Spanish
population (Continued)
Other endocrine, nutritional, blood, and
immune disorders
142.4 (83.1 ? 228.4) 199.8 (115.9? 362) 40% 474.8 (329.2? 710.6) 773.4 (529.7 ? 1,539.3) 63%
Musculoskeletal disorders 11,220.4 (,8585.2? 14,277.6) 14,278.5 (10,905.8? 17,775.5) 27% 11,469.4 (88,29.8? 14,558.2) 14,654.1 (11,291.8? 18,160.2) 28%
Rheumatoid arthritis 477.5 (345.2? 636.5) 665.5 (465.5? 881) 39% 519.4 (384.9? 684.3) 710.1 (509.5 ? 925.6) 37%
Osteoarthritis 1,055.3 (648.4? 1,604.3) 1,407.1 (877.8? 2,066.2) 33% 1,055.3 (648.4? 1,604.3) 1,407.1 (877.8? 2,066.2) 33%
Low back and neck pain 7,363.4 (5,148.2 ? 9,886.3) 9,178.1 (6,357.5? 12,295.1) 25% 7,363.4 (5,148.2? 9,886.3) 9,178.1 (6,357.5? 1,2295.1) 25%
Low back pain 4,784.5 (3,305.8 ? 6,484.6) 6,011.7 (4,104.5? 8,080.9) 26% 4,784.5 (3,305.8? 6,484.6) 6,011.7 (4,104.5? 8,080.9) 26%
Neck pain 2,578.9 (1,769.5 ? 3,608.8) 3,166.3 (2,193.9? 4,438) 23% 2,578.9 (1,769.5? 3,608.8) 3,166.3 (2,193.9? 4,438) 23%
Gout 21.6 (13.4? 32.1) 30.2 (19 ? 45.1) 40% 21.6 (13.4? 32.1) 30.2 (19 ? 45.1) 40%
Other musculoskeletal disorders 2,302.7 (1,585.5 ? 3,228.6) 2,997.7 (2,089.4? 4,136.6) 30% 2,509.7 (1,803.7? 3,433.4) 3,328.7 (2,440.8? 4,471.4) 33%
Other non-communicable diseases 4,700.2 (3,172.4 ? 6,899.1) 5,087.8 (3,400.3? 7,616.6) 8% 6,009.2 (4,467.8? 8,218.2) 5,881.5 (4,184.3? 8,375.2) −2%
Congenital anomalies 130.9 (93.7 ? 182.5) 141 (101.2 ? 201.8) 8% 1,278.3 (1,065.6? 1,416.6) 778.7 (685.8 ? 973.5) −39%
Neural tube defects 11.6 (6.4? 18.7) 8.2 (4.4? 13.6) −29% 99.4 (58.5? 126.5) 18.5 (12.5 ? 28) −81%
Congenital heart anomalies 34.2 (17.6? 66.8) 32.4 (15.9 ? 67.4) −5% 566.6 (460.8 ? 650.2) 321.4 (254.9 ? 411.9) −43%
Cleft lip and cleft palate 5.4 (2.7? 9.7) 6 (3.1? 10.5) 12% 7.9 (4.9? 12.4) 7.4 (4.3? 12.1) −6%
Down? s syndrome 38.1 (21.6? 61.4) 46.5 (27.1 ? 74.6) 22% 104 (69.3? 138.5) 104.7 (80.1? 136) 1%
Other chromosomal abnormalities 14.5 (8? 23.9) 17.4 (10.1 ? 29.2) 19% 59.4 (41.1? 78.5) 55 (39.2 ? 77.1) −7%
Other congenital anomalies 27.1 (19.1? 38.3) 30.6 (21.8 ? 44.9) 13% 441 (294.4? 539.7) 271.6 (215.5 ? 397.8) −38%
Skin and subcutaneous diseases 1,989.9 (1,235.6 ? 3,086) 2,206.8 (1,347? 3,476.9) 11% 2,058.2 (1,302? 3,150.8) 2,301.8 (1,445? 3,558.5) 12%
Eczema 462.2 (233.8? 802) 511.7 (252.5? 845.6) 11% 462.2 (233.8? 802) 511.7 (252.5 ? 845.6) 11%
Psoriasis 87.3 (42.4? 145.8) 105.1 (50? 172.9) 20% 87.3 (42.4? 145.8) 105.1 (50? 172.9) 20%
Cellulitis 11.1 (1.2? 45.6) 11 (1.3? 45.3) −1% 26.2 (15.7? 60.2) 29.6 (16.9 ? 63.8) 13%
Abscess, impetigo, and other bacterial skin diseases 41.8 (16.9? 85.1) 49.3 (19.8 ? 101.3) 18% 63.3 (38 ? 107.4) 76 (45.7 ? 129.6) 20%
Scabies 22.9 (10.1? 44.9) 26.2 (11.8 ? 49) 15% 22.9 (10.1? 44.9) 26.2 (11.8 ? 49) 15%
Fungal skin diseases 107.6 (33.8 ? 246.6) 128.2 (39.3? 291.8) 19% 107.6 (33.8 ? 246.6) 128.2 (39.3? 291.8) 19%
Viral skin diseases 189.2 (72.5 ? 359.4) 182.5 (66.3? 336.4) −4% 189.2 (72.5 ? 359.4) 182.5 (66.3? 336.4) −4%
Acne vulgaris 312.6 (139.6? 589.8) 237.6 (106.6? 469.3) −24% 312.6 (139.6 ? 589.8) 237.6 (106.6 ? 469.3) −24%
Alopecia areata 78.7 (23 ? 158.4) 91.1 (25.1 ? 182.4) 16% 78.7 (23 ? 158.4) 91.1 (25.1 ? 182.4) 16%
Pruritus 179.4 (82.5 ? 347.4) 244.2 (110.2? 489.4) 36% 179.4 (82.5 ? 347.4) 244.2 (110.2 ? 489.4) 36%
Urticaria 137.4 (55.3 ? 236.9) 159 (65? 271) 16% 137.4 (55.3 ? 236.9) 159 (65? 271) 16%
Decubitus ulcer 30 (9.8? 69.2) 40.3 (12.9 ? 96.9) 34% 61.5 (39.8? 101.6) 89.7 (55 ? 150.1) 46%
Other skin and subcutaneous diseases 329.6 (155.1? 610.6) 420.8 (193.8? 806.2) 28% 329.8 (155.2? 610.6) 421 (193.9 ? 806.3) 28%
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Table 3 Comparison of the main causes of disability-adjusted life years (DALYs) and years lived with disability (YLDs), in 1990 and 2010, for the Spanish
population (Continued)
Sense organ diseases 1637 (1164? 2335) 1,850.2 (1291.1 ? 2,656.9) 13% 1,637 (1,164? 2,335) 1,850.2 (1,291.1? 2,656.9) 13%
Glaucoma 36 (23? 54.9) 56.9 (37.6 ? 82.7) 58% 36 (23 ? 54.9) 56.9 (37.6 ? 82.7) 58%
Cataracts 193.1 (136.8? 261.7) 170.7 (116.3? 233.8) −12% 193.1 (136.8 ? 261.7) 170.7 (116.3 ? 233.8) −12%
Macular degeneration 58.4 (37.5? 87.3) 107.8 (71.8? 152.9) 85% 58.4 (37.5? 87.3) 107.8 (71.8? 152.9) 85%
Refraction and accommodation disorders 84 (61.3 ? 110.7) 107.9 (77.6? 142.3) 28% 84 (61.3 ? 110.7) 107.9 (77.6? 142.3) 28%
Other hearing loss 926.8 (541.4? 1480.3) 962.7 (554.5? 1598.5) 4% 926.8 (541.4? 1,480.3) 962.7 (554.5 ? 1,598.5) 4%
Other vision loss 329.9 (174.9? 586) 433.2 (222? 771) 31% 329.9 (174.9? 586) 433.2 (222? 771) 31%
Other sense organ diseases 8.8 (3? 19.8) 11 (3.7? 25.4) 25% 8.8 (3? 19.8) 11 (3.7? 25.4) 25%
Oral disorders 942.4 (564.3? 1507.7) 889.8 (519.4? 1403.9) −6% 942.4 (564.3 ? 1,507.7) 889.8 (519.4 ? 1,403.9) −6%
Dental caries 110.2 (45 ? 216.1) 130.4 (52.8? 250.1) 18% 110.2 (45? 216.1) 130.4 (52.8? 250.1) 18%
Periodontal disease 143 (54.8? 312.3) 193.8 (72.6? 400.1) 36% 143 (54.8? 312.3) 193.8 (72.6? 400.1) 36%
Edentulism 689.2 (394.8? 1103.5) 565.6 (322? 903) −18% 689.2 (394.8 ? 1103.5) 565.6 (322? 903) −18%
Sudden infant death syndrome 0 (0? 0) 0 (0? 0) ? * 93.3 (40.6? 150.8) 61 (31.4 ? 111.4) −35%
Injuries 3,873.3 (2,679.9 ? 5,500.9) 5,495 (3,846.6? 7,727.1) 42% 11,961.1 (10,559.1? 13,749.9) 9,962.5 (8,154? 12,170.7) −17%
Transport injuries 1,134 (763.2? 1,670.3) 1,428.6 (975? 2,074.9) 26% 4,925.5 (4,315.5? 5,683.5) 3,047.6 (2,494.2? 3,809.3) −38%
Road injury 982.9 (659? 1,450.2) 1,197.1 (810.2? 1,745.7) 22% 4,671.5 (4,049.7? 5,342.3) 2,692.9 (2,226.1? 3,328.1) −42%
Pedestrian injury by road vehicle 169 (113.6? 248.3) 243.2 (165? 350.8) 44% 580.3 (487.4? 761.5) 464.4 (372.3 ? 584.4) −20%
Pedal cycle vehicle 18.8 (12.7? 27.8) 50.5 (34.2 ? 74.1) 169% 71.2 (53.8? 110.9) 107.2 (75.3? 136.5) 51%
Motorized vehicle with two wheels 232.4 (155.6? 347.3) 172.6 (116.1? 252.7) −26% 1,423.3 (1,009.6? 1,638.8) 436 (360.3 ? 539.5) −69%
Motorized vehicle with three or more wheels 576.6 (386.6? 852.7) 779.7 (527.3? 1134.8) 35% 2,579.1 (2,156.9? 3,157.2) 1,722.1 (1,368.2? 2,279.8) −33%
Road injury other 13 (8.8? 19.2) 12.1 (8.2? 17.4) −7% 44.6 (31.7? 60) 24 (17.7 ? 33.7) −46%
Other transport injury 151.1 (102.4? 223) 231.5 (157.9? 331.2) 53% 254 (189.8? 359.6) 354.8 (275.4 ? 460.4) 40%
Unintentional injuries other than transport injuries 2,638 (1,821? 3,727.8) 3,944 (2,760.5? 5,515.8) 50% 5,486.5 (4,503.8? 6,659) 5,472.7 (4,205.3? 7,082.7) 0%
Falls 2,150.2 (1,471.2 ? 3043.3) 3,315.8 (2,316.6? 4,644.3) 54% 2,462.8 (1,754.8? 3,385.5) 3,763.4 (2,726.7? 5,125) 53%
Drowning 9.7 (6.1? 14.5) 11.1 (7? 16.8) 14% 404.4 (312.7 ? 497.3) 222.8 (181? 295.5) −45%
Fire, heat and hot substances 57 (30.5 ? 106.3) 70.2 (37.6 ? 127.1) 23% 158.1 (122.4? 213) 141 (105.1 ? 202.2) −11%
Poisonings 9.2 (5.6? 14.6) 7.1 (4.3? 11.3) −23% 220.6 (153.6 ? 338.5) 165.9 (79.7? 233.9) −25%
Exposure to mechanical forces 72.6 (45.5? 114) 75.2 (47.8 ? 113.9) 4% 269.1 (212.6? 366.4) 185.4 (130.8 ? 252.4) −31%
Mechanical forces (firearm) 26.9 (17? 42.2) 14.6 (9.4? 22.2) −46% 94.8 (56.5? 123) 31.6 (22.7 ? 47.7) −67%
Mechanical forces (other) 56.5 (35.4? 88.2) 79.1 (50.2 ? 119.5) 40% 185.1 (147.6? 282.1) 172.3 (131.7 ? 241.7) −7%
Adverse effects of medical treatment 45.3 (29.2? 68.3) 102.6 (66? 151.3) 127% 143.5 (115.6? 181.7) 227.3 (174.5 ? 307.9) 58%
Animal contact 21.9 (14.2? 32.8) 11.7 (7.7? 17.2) −47% 35.3 (26.2? 47.7) 18.6 (14 ? 25.1) −47%
Animal contact (venomous) 14.3 (8.7? 22.3) 6.8 (4.3? 10.5) −53% 16.4 (10.6? 24.8) 8.3 (5.6? 12.2) −50%
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Table 3 Comparison of the main causes of disability-adjusted life years (DALYs) and years lived with disability (YLDs), in 1990 and 2010, for the Spanish
population (Continued)
Animal contact (non-venomous) 7.6 (4.8? 11.8) 4.9 (3? 7.3) −36% 18.9 (13.9? 24.7) 10.3 (7.8? 13.9) −45%
Unintentional injuries not classified elsewhere 272.1 (185.1? 396.4) 350.3 (232.7? 505.7) 29% 1,792.7 (1,054.8? 2,031) 748.2 (605.7 ? 955.4) −58%
Self-harm and interpersonal violence 101.3 (66.6 ? 146.4) 122.3 (81.1? 173) 21% 1,549.1 (1,277.2? 2,016.4) 1,442.2 (1,051.7? 1,690.9) −7%
Self-harm 12.6 (7.9? 18.3) 15.2 (9.7? 23.1) 21% 1,244.6 (9,62.4 ? 1,686.8) 1,154.4 (7,59.7? 1,377.5) −7%
Interpersonal violence 88.7 (58.4? 129.4) 107.1 (70.8? 151.4) 21% 304.5 (241.9? 403) 287.8 (230.5 ? 369.8) −5%
Assault by firearm 23.2 (15 ? 34.3) 30.1 (19.5 ? 42.9) 30% 74.6 (59 ? 105.3) 74.2 (57.3 ? 98.9) −1%
Assault by sharp object 31.9 (20.9? 46.9) 56.2 (37 ? 79.6) 76% 106.7 (79.1 ? 175.7) 143.2 (94.8? 186.6) 34%
Assault by other means 40.1 (26.5? 57.7) 31.3 (21 ? 43.8) −22% 129.7 (98.4 ? 158.1) 80.9 (65.5 ? 106) −38%
Data are presented as mean values and uncertainty intervals (Lower, Upper).
*? not applicable.
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1990  Main causes for DALYs
1 Cardiovascular and circulatory diseases
2 Neoplasms
3 Musculoskeletal disorders
4 Mental and behavioral disorders
5 Diabetes, urogenital, blood, and endocrine 
diseases
6 Other non-communicable diseases
7 Chronic respiratory diseases
8 Unintentional injuries other than transport 
injuries
9 Transport injuries
10 Neurological disorders
11 Diarrhea, lower respiratory infections, 
meningitis, and other common infectious 
diseases
12 Cirrhosis of the liver
13 Digestive diseases (except cirrhosis)
14 Self-harm and interpersonal violence
15 HIV/AIDS and tuberculosis
16 Neonatal disorders
17 Nutritional deficiencies
18 Other communicable, maternal, neonatal, 
and nutritional disorders
19 Neglected tropical diseases and malaria
20 Maternal disorders
2010  Main causes for DALYS %
1 Neoplasms 14%
2 Cardiovascular and circulatory diseases -11%
3 Musculoskeletal disorders 28%
4 Mental and behavioraldisorders 23%
5 Diabetes, urogenital, blood, and endocrine 
diseases
20%
6 Neurological disorders 61%
7 Other non-communicable diseases -2%
8 Unintentional injuries other than transport 
injuries
-0,3%
9 Chronic respiratory diseases -6%
10 Transport injuries -38%
11 Diarrhea, lower respiratory infections, 
meningitis, and other common infectious 
diseases
-8%
12 Digestive diseases (except cirrhosis) 11%
13 Cirrhosis of the liver -25%
14 Self-harm and interpersonal violence -7%
15 Neonatal disorders -28%
16 HIV/AIDS and tuberculosis -52%
17 Nutritional deficiencies 13%
18 Other communicable, maternal, neonatal, 
and nutritional disorders
8%
19 Neglected tropical diseases and malaria -7%
20 Maternal disorders -22%
Figure 3 Spanish disability-adjusted life years (DALYs) ranks for the top 20 main causes in 1990 and 2010, and the percentage change
between 1990 and 2010. Continuous line represents an ascending order in rank and the broken line represents a descending order. (Δ%) = %
of change in absolute numbers of DALYs.
Figure 4 DALYs in Spain by cause and age in 2010. Adopted and modified from GBD data visualizations.
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Figure 5 Age-standardized YLDs ranking relative to comparator European countries by the top 20 causes in (A) 1990 and (B) 2010.
Numbers in cells indicate the ranks by country for each cause, with 1 being the disorder with the highest impact. The presented causes are
ordered by the 20 leading causes of YLDs in Spain. YLDs, Years lived with disability; COPD, Chronic obstructive pulmonary disease. Adopted and
modified from GBD data visualizations.
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tion growth of 15% between 1990 and 2010 and the age-
ing of the population, the burden of disease increased
only by 5%. The analysis of changes by age and gender
group denoted that DALYs decreased when analyzed as
rates per 100,000 population.
The relevance of neoplasms and cardiovascular and
circulatory diseases on population health is mostly driven
by mortality. Accordingly, the cardiovascular and circula-
tory diseases, neoplasms, and injuries due to transport rea-
sons were the top three leading causes for the burden ofYLLs. However, the impact of musculoskeletal disorders
and mental disorders is mostly through YLDs, since
they are the first and second causes in the ranking.
Together, these two groups of disorders, accounted for
almost the half (48%) of all YLDs in Spain. Additionally,
depression, and other mental disorders (like anxiety,
etc.) have been associated to various musculoskeletal
disorders [17,18]. All these conditions are related to
occupational risk, particularly low back pain [19], and
absenteeism. The impact of these disorders and the
need for mental health promotion and musculoskeletal
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public health authorities and policies [20].
Other studies have previously evaluated the burden of
morbidity and mortality in Spain [8,9]. According to these,
in 2008, the major causes for mortality in males and fe-
males were also cardiovascular diseases and malignant
neoplasms [8]. Furthermore, a recent study in Valencia re-
ported similar results in mortality rates in the local popu-
lation (i.e., 26% of all deaths due to malignant tumors and
34% due to cardiovascular diseases [9]).
Clear gender differences emerged in the analyses. Spe-
cifically, in males, cancer (i.e., neoplasms) was the main
mortality cause followed by cardiovascular diseases, while
in females the order was reversed. Risk factor differences
may be causing the increased impact of cancer in males:
they still have higher rates of smoking and heavy alcohol
consumption [21,22]. The increased mortality of cardio-
vascular diseases in females is due to cerebro-vascular
problems. Further, hormonal factors (disappearance of the
protective role of estrogens after menopause) have been
associated to the increased risk of stroke in females [23].
The top five causes for the burden of YLDs in Spain
are similar to those in the other Mediterranean coun-
tries (except for slight differences with France) [24-26].
Similar results appeared also in the burden of DALYs
comparing Spain to other European countries [24-26].
These similarities in the Mediterranean population ? s
health could be a result of the common lifestyle habits
(dietary habits, smoking, physical activity, etc.) [27], as
well as shared genetic traits within the region [28].
Spain, as well as other Mediterranean countries, has to
shift the provided health care services from curative to
preventive [29,30] and to identify the priority diseases
for health research funding and prevention policies
development [8].
When comparing the results among all European coun-
tries, some remarkable results have also been found.
While there are substantial differences in the rank order
of diseases regarding DALY? s [7], there are much less dif-
ferences in the first five causes of YLDs across European
countries. Country differences may be mostly caused by
differences in mortality instead of differences in YLDs.
Whether this can be attributed to mortality figures being
recorded more systematically in each country than preva-
lence figures should still be clarified.
In 2010, Spain presented the same leading conditions
for YLLs compared to other Mediterranean countries,
such as Greece, France, and Italy [24-26]. In 2010, Spain,
France, and Italy showed age-standardized YLL rates for
liver cancers significantly higher than the overall mean
rate. Spain and Greece showed significantly higher rates
of age-standardized YLL rates for bladder cancers [7].
Besides, the leading causes for premature mortality in
the UK seem to be similar with those in Spain (i.e.,cardiovascular and circulatory diseases and trachea,
bronchus, and lung cancers [24-26]).
Globally, there is continuous shift from communicable
to non-communicable diseases as the leading causes of
mortality and DALYs [2,5]. According to the latest data
for 2010, in the top ten leading causes of population ? s
mortality, five were classified as non-communicable [2].
Global DALYs remained stable from 1990 to 2010 [5].
However, the global age-standardized DALY rates [5] ac-
tually decreased, which is consistent with our findings in
Spain. Ischemic heart disease was the leading cause of
DALYs worldwide in 2010, followed by lower respiratory
infections, stroke, diarrheal diseases, and HIV/AIDS. De-
pressive disorders, also climbed from the fifteenth to the
eleventh rank and road injury from twelfth to tenth rank
[2,5]. However, in Spain the major causes for DALYs
were neoplasms followed by cardiovascular diseases, mus-
culoskeletal disorders, and mental disorders. Neurological
disorders moved from the tenth to sixth rank; this high
ranking in musculoskeletal disorders was quite similar
with the global estimates [5] ? low back pain and neck
pain are the most important contributors accompanied
by osteoarthritis, rheumatoid arthritis, and gout [5,31].
The pathophysiology of chronic diseases, especially car-
diovascular diseases and cancers, is complex, with the
interaction of new environmental risk factors (e.g., multi-
morbidity, financial status, etc.), in addition to the classical
modifiable risk factors (i.e., cognition reserve, smoking,
unhealthy diet, physical activity, hypertension, etc.), mak-
ing the prevention of chronic diseases in older adults quite
difficult. Efforts to improve and protect health, prevent
disease and injury, and deliver high-quality health care to
the population must be tailored to address the causes as-
sociated with the greatest burden mainly of chronic dis-
eases [32]. It is expected that preventive strategies can
influence many of the aforementioned chronic conditions
and non-communicable causes and increase the quality of
life, while averting or minimizing the need for expensive
medical care [33,34]. Furthermore, the engagement with
the GBD collaborative group will provide more and better
analysis data of the global burden of disease and, specific-
ally, in Spain ? a fact that will contribute to continuous
improvements of the health estimates in future iterations
of the GBD study.
Limitations
The previous results should be considered taking into
account the following limitations. Although Spain fol-
lows the European Statistics Code of Practice of 2006 ?
2008 and data is collected in a consistent way across the
country, there are a number of issues that should be
considered when analyzing the results. Regarding mortal-
ity, the GBD project defined a number of garbage codes,
which are causes of death that should not be identified as
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underlying causes of death on death certificates. Garbage
codes were substituted by underlying causes based on
pathophysiology. The fraction of garbage codes in Spain
was within the world average. The substitution of garbage
codes has impact on mortality causes. For example, in
2010, transport injury deaths based on raw data from
Spain were 2,257. After correction for garbage codes
and other adjustments, this number increased to 3,657
deaths. Following the modeling process, it further in-
creased to 3,950.
In this study, the calculation of DWs were based on sur-
veys including several countries, and not just Spain. How-
ever, according to recent results [10], the DW assessments
appeared to be consistent even among different cultural
environments. Another aspect is the prevalence of the
referred health conditions, which was based on epide-
miological studies, a fact that may create uncertainty
depending on the quality of the primary data. To over-
come this issue, some expert groups developed tools to
assess the risk of bias in the selected studies and sensi-
tivity analyses were performed to weight study sizes ac-
cording to their quality, or even to eliminate them from
the final analysis [10]. As referred in previous works of
the GBD study [10], Bayesian statistical models were
used to estimate prevalence of conditions in each coun-
try by age, sex, and year. The nature of this estimation
process implies that, in some cases, depending on the
covariates, estimated variance might be smaller than
the real variance across countries in a region, and in
some other cases, uncertainty intervals for a specific es-
timate might be exaggerated. Furthermore, the calcula-
tion of uncertainty intervals throughout the Bayesian
model analysis has provided some information on the
extent of available information for Spain. However, the
nature of the estimation process for causes of death and
the prevalence of sequelae more generally lead to exagger-
ated uncertainty intervals in a high-income country such
as Spain [12]. These wide uncertainty intervals may limit
the number of the detected significant changes in the bur-
den of disease between 1990 and 2010.Conclusions
The present findings, together with previous work [5],
suggest that cardiovascular and circulatory diseases, neo-
plasms, and mental and neurological disorders seem to
be the leading causes of mortality as well as for YLDs
and DALYs in Spain. Although several health promotion
action plans have taken place globally [35,36] in the past
few years, morbidity throughout non-communicable
diseases is increasing at alarming rates. Public health
care systems have to focus further on the quality of
health care services [37]. Furthermore, health promotionstrategies should focus on health education programs
that could improve quality of life. Public health care ser-
vices have to shift from being curative to being prevent-
ive; in Spain, a strong emphasis should be given on
health promotion, disease prevention, and rehabilitation.
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